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1
Abstract
Metabolomics is a technology which allows us to probe a wide array of interactions between
metabolites. These interactions can be revealed by statistical correlations between metabolite
levels that may arise via a range of mechanisms. To measure metabolite levels, two main tech-
niques are used: Liquid Chromatography Mass Spectrometry (LC-MS) and Nuclear Magnetic
Resonance (NMR). For the measurement of correlation structure high analytical reproducibility
of the assays is required. While NMR has previously been shown to be reproducible, LC-MS, has
not been similarly assessed. To assess the reproducibility of LC-MS for urinary metabolomics,
a multi-laboratory study was devised. We find that the technology is highly reproducible, both
within and between laboratories with CVs of < 17%, < 5s drift and under 10% ppm between
labs.
In LC-MS, ionisation of a single compound can lead to multiple charged species such as iso-
topologues, adducts etc. These multiple signals have a high mutual correlation and we show
that this allows them to be identified with high sensitivity and specificity. The inferred statistical
interactions between different metabolites can also be affected by analytical errors. An algorithm
was designed to remove statistical metabolite links that could have been caused by the analytical
technique. Using this method, a higher confidence can be placed on the remaining interactions,
suggesting that they are potential biological interactions. Finally, most biological interactions are
dynamic in nature, leading to correlations through time between metabolite levels. To explore
these dynamic links, two temporal approaches were developed. These methods are designed to
discover temporal correlations between metabolites and to test whether they vary between bio-
logical conditions. We successfully demonstrate the methods in both LC-MS and NMR datasets.
Overall, this thesis shows that correlation structure in metabolic profiling data is reliable, can
be successfully filtered to improve quality and can be interrogated to reveal a new kind of dy-
namic metabolic biomarker.
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1 Introduction
1.1 Metabolite Profiling and its Background
Metabolites are the basic building blocks of any biochemical reaction. To understand these re-
actions, the kinetics, the products of the reactions and the effect would be to obtain a broad
understanding of the biological system. This is to say they are a phenotype of the system. These
metabolites are readily available from any biofluid or tissue. Collection from biofluids, such as
blood or urine, eases ethical constraints, makes collection of samples simpler and makes medical
diagnosis faster as there is less extraction work to do. For these reasons and more, metabo-
lite profiling has become a promising new field and has been rapidly developing in the last 15
years [1–4]. Similar techniques and principals were described in 1966 by Dalgliesh [5]. In
this publication Dalgliesh described how using a high through put methods such as Gas Chro-
matography Mass Spectrometry (GC-MS), would allow for the profiling of many metabolites to
observe their changes in reaction to a stimuli. Later, Pauling et al [6] also published work in
1971 where they could observed around 250-280 metabolites using GC-MS analysis on breath
and urine vapour samples. Using 31P Nuclear Mass Resonance Spectroscopy (NMR) Hoult et
al, published in 1974 a method of to look at metabolites in tissue [7]. He described a complex
experiment where using NMR, energy metabolism and its dynamics where observed by using
Phosphorus NMR containing molecules such as ATP. While the ideas of profiling the metabo-
lites in order to understand the biological system and find unique metabolites to classify diseases
11
were known and being practiced before they not defined in a publication until 1998-9 [2, 8, 9].
The paper in which the ideas of the field of metabolomics were described was part of a sys-
tem wide understanding of yeast (S.cerevisiae). A publication by Oliver et al in 1998 [8, 10]
was the first to refer to the metabolome. While the metabolome was not strictly defined in the
publication it was understood to be ’the collection of small molecules produced by cells’ [3].
During this starting period of the field another term, rooted in greek origin, metabonomics was
defined by Professor Jeremy Nicholson. It was defined as ”the quantitative measurement of the
dynamic multiparametric metabolic response of living systems to pathophysiological stimuli or
genetic modification”, meaning that ”metabonomics deals with detecting, identifying, quanti-
tating and cataloguing the history of time-related metabolic changes in an integrated biological
system” [2]. The accepted difference between the two terms being mainly that the metabolome
is an all encompassing term to profile all of the metabolites, where as metabonomics looks to
profile metabolites in a sophisticated dynamic manner.
Many biomarkers have been discovered from metabolite profiling such as Taurine and Malic
acid for myocardial injury [11], Oleamide for Hepatocellular Carcinoma [12] and even dietary
biomarkers such as Dihydroferulic acid for coffee [13], proline betaine for citrus fruits [14] and
many more [15, 16]. While biomarkers for different disease and or changes are helpful and po-
tentially life saving, understanding the metabolome has also been an area of intense research for
metabolomics. In plant metabolomics it has helped to find and identify novel secondary metabo-
lites [17, 18] and to database plant metabolites [19, 20]. Metabolite profiling has also started to
address difficult and complex medical questions showing a strong link between gut microbiota
and human diseases [21, 22], a molecular understanding of the plasticity of stem cells [23],
molecular models for the early detection of preeclampsia during pregnancy [24, 25] and much
more [26, 27].
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1.2 Analytical Platforms for Metabolite Profiling
While there are many ways to detect and analyse metabolites from a biological system there are
two main detection systems. One is Nuclear Magnetic Resonance and the other is a hyphened
technique of Liquid/Gas Chromatography-Mass Spectrometry. Both of these techniques allow
for a high throughput analysis and can analyse tens to thousands of metabolites in a single run.
1.2.1 Nuclear Magnetic Resonance Spectroscopy
Nuclear Magnetic Resonance (NMR) was developed and discovered by Professor Rabi in 1939 [28,
29]. The idea is to use the physical properties of certain atoms’ nuclei that have a property called
spin. Only certain nuclei have the property, some of the common ones are 1H, 13C, and 31P. The
nuclei act as little magnets, these magnetics can be aligned or mis-aligned with a given magnetic
field. The nuclei that are aligned to the magnetic field are at a lower, more stable energy state
than the mis-aligned nuclei. The nuclei will absorb different radio frequencies (RF) depending
on which nuclei (ie 1H, 13C etc) and the magnetic field strength of the local magnetic field. Each
nucleus on a particular atom has a slightly different environment. These different environments
have different densities of electrons around them, this will affect the field local strength. This
altering is due to the electrons on the neighbouring atoms that induce their own magnetic field.
This can either add to or subtract from the external field. The nuclei will absorb energy at E = hν.
Where E is the energy that they absorb h is Planck’s constant and ν is the frequency of the radio
frequency (RF). This absorbed energy will make the nuclei flip to the higher energy state. How-
ever, as the lower energy state is more stable the nuclei will flip back to the lower state releasing
the same RF as they absorbed. Since a wide range of RF were pulsed at the sample and only cer-
tain RF were absorbed only those RF are resonated back. This allows detection of environments
of the nuclei of each atom. However, since every magnet field strength is different the resonance
frequencies will be different on each spectrometer. These frequencies can ’normalised’ to a mea-
13
sured compound such as tetramethylsilane (TMS). By normalising the spectra to TMS there is
now a base line which is made by the first signal of the TMS at roughly 100MHz on 9.4 Tesla
NMR. The frequencies are measured in parts per million (ppm) shifts less from what the TMS
baseline needed to produce a signal. This can now be plotted with the intensity of the resonated
frequencies that were received by the NMR detector to make a spectrum. By knowing the the
different ppm shifts a molecule can be described and structurally characterised.
The two main NMR experiments 1H NMR and 13C NMR require different pulse frequencies
and need to be performed in separate experiments. The 13C experiments take a much longer
time than the 1H experiments. This is due to the lower natural abundance of 13C as opposed to
1H. 1H NMR experiments also have their own problems. Most samples need to be in a solvent
however, most solvents have 1H. If a solvent with 1H was used then the signals from the solvent
would dominate the analyte signals. Therefore, if a 1H NMR experiment is being done all of the
solvents used need to be deuterium 2H solvents. However, if this is unavoidable specific signals
such as water can be suppressed with negatives pulses. 2H will also absorb RF and have spin
however, they will absorb at a different wavelength than the 1H.
NMR spectroscopy is very useful in metabolomics since it allows for a quick understanding
of what compounds are in the mixture and can yield a lot of information quickly. NMR also
has the advantage that it is relatively easy to use and the reproducibility of the technique is very
high. This means that samples can be compared from different labs and still have the same results
which is essential in the larger studies that are becoming more frequent.
14
1.2.2 Liquid Chromatography Mass Spectrometry
Liquid Chromatography
There are many different types of chromatography of which liquid chromatography is one. Liq-
uid Chromatography (LC) is one of the most commonly used chemical separation techniques.
In this technique, the chromatographic separation takes place by a competition between a tube
packed with small solid particles, called the chromatographic column (stationary phase) and a
liquid mobile phase. Nowadays a lot of chromatographic columns can be found in the market
depending on the chemistry of the small particles they contain. These are normally porous silica
particles however, newer technology have allowed polymeric particles to be used as well.
In metabolomics both gas chromatography (GC) and LC are used frequently [30, 31]. In LC a
commonly used type of method is the reversed phase (RP) chromatography. In RP chromatogra-
phy [32], the most widely used chromatographic columns are packed with porous silica particles
that are linked to C8 or C18 alkyl chains. These alkyl chains have a hydrophobic interaction with
the analytes.
The analyte is initially dissolved in the mobile phase and once it reaches the chromatographic
column it interacts with both phases at the same time. In RP chromatography the mobile phase
is normally a mixture of water and organic solvent, that is substantially more polar than the sta-
tionary phase. As the mobile phase is flushed through the chromatographic column, analytes
elutes faster or slower, depending on their partition coefficient and the non-polar analytes bind
more strongly to the stationary phase particles than polar ones. By increasing the percentage of
non-polar solvent (normally acetonitrile or methanol) the mobile phase turns less polar and thus
elutes the retained analytes more quickly. This change is known as a gradient elution and the
length and ramp of the gradient depends upon factors such as the amount of separation desired,
complexity of the sample, the pressure used in the LC system and the solvents used. High Pres-
sure LC (HPLC) [33] (50-350 bar) allows a good separation of complex samples and the typical
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run time is around 30-45 mins for a metabolite profiling experiment. However, if the particle
size of the stationary phase is significantly decreased (from 3 − 5µm to 1.7 − 1.8µm) then the
system pressure is increased to 600-1200 bar and the same separation can be achieved within
less run time. This means that the LC chromatographic peaks are narrower, which in-turn can
increase the analytical sensitivity. These systems are known as ultra performance LC (UPLC)
systems [34]. LC systems are only separation techniques, thus they need a detection system,
such as UV detectors or inline mass spectrometry.
Mass Spectrometry
Mass spectrometry (MS) is a frequently used and popular technique in analytical chemistry and
metabolomics. It works on the principal that chemicals can be charged/ionised and then manip-
ulated. Once the chemicals are ions they can be introduced into the MS and its mass, ion charge
ratio and relative amount can be measured. Once the molecule/chemical is an ion it can be ma-
nipulated by electromagnetic fields and guided through the instrument, filtered or separated and
finally measured. The mass spectrometer records two measurements, the mass-to-charge ratio
(m/z) and the number of ions hitting the detector (counts).
The process of ionisation is a complex and not fully understood process. There are many ways to
make ions. The main decision is whether to use a solid support system, a liquid based ionisation
or gas based. While there are many different ionisation systems [35–39] they can be broken up
into the following main ionisation techniques:
• Matrix Assisted Laser Desorption/Ionisation (MALDI) - This is a solid support technique.
A small amount of the analyte is deposited on a stainless steel plate with an equal amount
of matrix. Matrix is a crystalline structure that absorbs energy from the laser. As this
energy is absorbed the matrix desorbes from the plate and ionises in a plume. In this
plume the matrix releases the energy given to it by the laser and gives it to the analyte.
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Thus, the analyte is now ionised. The full mechanism of the MALDI process is not fully
elucidated [40]. A drawback from this ionisation method is that both the analyte and matrix
are seen in the final measurement. This co-ionisation can interfere with low molecular
weight molecules such as metabolites.
• Electron Impact and Chemical Ionisation (EI & CI) - Electron impact and chemical ionisa-
tion are older techniques of ionisation. EI works by hitting the analyte, which is normally
in the gas phase, with an electron beam. This method of ionisation is a high energy ion-
isation and so the molecule can fragment when this happens. Also, the method does not
produce a [M + H]+ or [M − H]− ion as in other ionisation methods. The simplest ion
that can be formed is the addition of an electron or the removal of an electron [M + .]− or
[M − .]+. Chemical ionisation works in a similar fashion as EI and is also used on samples
that can be analysed in the gas phase. With CI a primer gas such as ammonia or methane
are ionised with an EI source. Then the charged gas is pressurised into the source cell with
the analyte. The charge is then transferred between the gas ions and the analyte. CI is
useful due to a softer ionisation and consequently lower fragmentation.
• Electrospray Ionisation (ESI) - This is the most common ionisation method in metabo-
lite profiling. ESI is a low energy ionisation technique and so allows for the analysis of
biomolecules with little fragmentation. ESI works by charging the injection needle with a
very high voltage. The analyte liquid is then passed through this needle. Due to the high
voltage of the needle the liquid is sprayed out of the needle in a cone shape. The needle
and orifice of the MS are inside a chamber. This chamber is heated and is kept dry with
continuously blowing nitrogen gas. This cone, referred to as a Taylor cone, then beads off
droplets which undergo evaporation and Coulomb fission. Coulomb fission is an explosion
of the droplets due to repulsion forces from the same charged ions. This process happens
repetitively until the single charged molecule/chemical (ion) is left with no solvent. This
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process was popularised by John Fenn et al when they understood how multiple charged
ions were being formed during the electrospray process [37]. These ions are attracted to-
wards the instrument by opposite charges. This is shown in figure 1.1
All ionisation techniques produce more than one charged ion species per molecule. In ESI &
MALDI the simplest and most sought after ion is the molecular ion or the molecule with or with-
out a hydrogen atom ([M + H]+ and [M−H]−). However, ions can also be formed with any other
atom that is the same charge as the charge given in the source. For example in positive mode
another common ion is the sodium adduct [M + Na]+ or more complex ions such as a water loss
in negative mode [M − H2O − H]−. These other possible ions are collectively called adducts.
These adducts can complicate detection, quantitation and identification of interesting results.
To separate out the different ions a separation chamber, mass analyser is needed. There are a
lot of different options each with their own benefits and drawbacks. A few of the most popular
ones are :
• Quadrupole - This is an older, low resolution separation technique. The ions are separated
by four hyperbolic rods which have opposite charges. When these charges are applied,
each of the opposite pairs of rods have a different charge, i.e. negative or positive. The
ions are then attracted towards the rods and repelled from the opposite pair of rods. The
rods then swap charges and so the ions have a forward cylindrical motion. Ions that are not
stable in this environment due to the applied electric field will hit the rod. However, stable
ions will reach a detector at the end of the quadrupole. By constantly scanning different
RF’s a range of m/zs can be filtered.
• Ion Traps - Ion traps (Paul ion traps) work on a similar concept as quadrupoles. However,
the ions are trapped and are ejected from the trap to the detector when the RF are changed
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Figure 1.1: An overview of chemical detection using electrospray ionisation and the time of flight
mass spectrometer detection with an electron multiplier. As droplets leave the high
voltage needle they enter into a high temperature chamber and gather a charge from
the needle. The droplets undergo coulomb fission until a single ion is left. The ions
enter into the flight tube and are accelerated by the pusher down the flight tube and
around the reflectron until they hit the detector. In the detector the signal is amplified
by a electron multiplier.
so that the ions are no longer stable in the cell. Ion traps suffer from a low resolution and
low dynamic range due to limited capacity to fill the cell with a wide range of ions.
• Fourier Transform Ion Cyclotron Resonance (FT-ICR) - This is by far the highest reso-
lution mass spectrometer filter. However, it is also the most complex instrument to run
and has high running costs. This instrument uses a high strength electro-magnet which
allows for the trapping of the ions in a Penning trap. Once trapped, the ions are excited
to their resonant cyclotron frequencies. As the ion packets oscillate they induce a charge.
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All of the ions produce this charge in unison and so a Fourier transformation is required to
transform the signal from the frequency domain to the time domain.
• Time Of Flight (TOF) - This is the most common mass analyser in metabolite profiling,
first described in 1949 by [41]. The analyser is considered to have a high resolution and
consequently can achieve a high mass accuracy. However, this is all dependant upon the
size of the flight tube. TOF systems work on the simple principle that larger ions will travel
slower than smaller ions and that ions that have more charge, than other ion will travel
faster. The ions are timed from a pusher where the ions are perpendicularly accelerated
down the flight tube to the detector as shown in figure 1.1. The ions are kept close to the
centre of the flight tube by a charged guide wire until they reach the detector. The detector
measures the time that it takes for ion packets to leave the pusher and arrive at the detector.
Therefore, the longer then flight tube, the better resolution. [42]
When LC is combined with MS an ultimate metabolite profiling platform is made. However, this
high throughput method comes at the price of complexity. The data has 3 measurements:
• Mass-to-charge ratio(m/z): The measured ratio of the mass and the charge of the ions.
• Retention time (RT): The time that the molecules eluted from the column.
• Intensity: The number of ions hitting the detector over a summed set of transients.
The resulting dataset has three different measurements. This complex 3D dataset makes data
analysis difficult and consequently it requires specialised software.
1.3 Data Preprocessing
There are many different tools that have been designed to extract and interpret data from metabolomics
experiments. Both NMR and LC-MS data have their own specialised software and scripts to al-
low successful data extraction and analysis. Data extraction can be difficult due to variance
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between samples within the dataset. This variance can cause a variable (a LC-MS or NMR peak)
to shift in its location on the spectral scale. Consequently, matching the same variable between
samples can be difficult. However, the end result of these data extractors is a list of variables
with metadata (in NMR, ppm values and in MS m/z & RT values) and intensities for each sample
in the dataset.
Typically, the experiments are setup to discover and detect a statistically significant metabolite
that differentiates a set of class groups. One particular example is the FaahKO data where a set of
mice had a gene knockout (KO) for the enzyme fatty acid amide hydrolase [43]. The experiment
compared the KO to the wild-type (WT) mice brain and spinal cord tissue for each metabolite
that was detected and assess if the metabolite concentration is different. For this purpose the
term class will refer to a predefined similar set of samples. Once these softwares have a list of
variables and their intensity values, a set of statistical test can be performed. The tests assesses
which variable is important in differentiating the class or classes.
1.3.1 Data Preprocessing Software Platforms - LC-MS
The area of mass spectrometry pre-process software has seen many different solutions to the
same problems. The main problem in LC-MS datasets is that the RT of the peaks shift from sam-
ple to sample. This is due to many different reasons, such as column degradation, non-efficient
mixing of the solvents over the gradient and any outside factors that effect the column. This RT
shifting causes an extra layer of problems in trying to match peaks between samples [44].
The software that extracts the data deals with these problems in a variety of different ways.
However, before the peaks can be aligned they must first be extracted from the raw data and
sorted into potential groups of peaks. While it is not always true that the software follows this
sequence, it must complete the steps below at some point during its processing.
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• Peak Detection - An algorithm that detects the signal from the noise. These algorithms use
a filter function to assess if a possible peak fits to the specified function. These functions
are often Gaussian or (mexican hat) wavelet functions. Using the fitted function the peak
is integrated to find the area of the peak. The peak area has been shown to be more reliable
than maximum peak intensity [45].
• Grouping - An algorithm that collects peaks within the same RT and m/z. Once the peaks
are grouped they are referred to as ’features’. Grouping is often difficult and can lead to
overlapping features being grouped together. RT alignment can help to reduce this problem
along with choosing the correct m/z & RT windows.
• Retention time alignment - This is probably the biggest area of divergence in the field.
The role of these algorithms is to correct for shifts in RT between samples for each set of
features.
• Back filling - Not all software offer this option. The software goes back to the raw data
if a peak was not detected in the sample for that feature. This is to say that in the classic
KO vs WT experiment, if there are no peaks detected in the KO class for a feature then
the software will go back to the KO samples and integrate whatever signal or baseline was
present at that RT and m/z
As previously, stated all of these software platforms have difference between them. Below is a
list highlighting some of the differences between the softwares and how they cope with these
problems.
• Mass Profiler Pro - Commercial software from Agilent. This software is specifically tai-
lored to the Agilent platform but does posses the ability to work with other instruments.
It relies heavily on the ability to detect isotope patterns, fragments and adducts. With this
information it uses these peaks to make a compound list. With the compound list it can
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then generate a ’true retention’ time alignment and grouping is a manually assisted but
uses the compound detection to aid in correct grouping.
• Progenesis CoMet - A commercial piece of software from Nonlinear Dynamics. Usable on
all LC-MS platforms. This platform takes care of the alignment at the start of the process.
Using image based software to align all of the LC-MS datasets to one global alignment.
From this global alignment the peaks are then detected using added information about
the isotope pattern and possible adducts. Since all of the data has been aligned to a global
image the intensities for each of the peak can then be read independently from each file and
compared between class groups. CoMet also makes use of the compound detection which
is possible with the isotopes and adducts but groups the peaks that have not been detected to
be a compound. Afterwards, a wide array of different multivariate and univariate analysis
can be performed.
• mzMine - This is a well used open source software (OSS) platform that has been ex-
tended and continuously developed [46, 47]. Relying heavily on the graphical user inter-
face, mzMine has incorporated some preprocessing sets such as SavitzkyGolay smoothing
filter. For peak detection, there are many options, from simple detection of peaks above
noise to a wavelet based algorithm [48] originally developed in xcms [49]. The RT align-
ment uses the RANdom SAmple Consensus (RANSAC) algorithm. This algorithm tries to
group and align in one set. By using all of the features in the dataset, it makes a model for
each set of features. The samples where peaks are outside of the model are then aligned to
that RT.
• xcms - This is one of the most well used data platforms in the field. It is extendable OSS
which has had many extensions published for it [48, 50–53].
XCMS has two main peak detection methods. The first, matched Filter, uses a binned ma-
trix. A user defined amount of bins are then combined and a second-derivative Gaussian
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filter is then fitted to the bins. The bin is a slice of m/z and RT so that each filter is being
applied to an defined area of the chromatograph, or an extracted ion chromatogram (EIC).
The other option is a high resolution peak detection algorithm called centWave [48]. This
algorithm works by automatically detecting which area to apply the filter to. It does this by
using a separate algorithm called region-of-interest (ROI). The ROI detection is a tracker
algorithm based on the Kalman filter [54]. After an area of the chromatogram has been
found to be a possible peak a mexican hat wavelet is used as the mother wavelet. The peak
is fitted using a scaling Continuous Wavelet Transform. The final scale that the wavelet
uses can be used for integrating the peak which is robust to noise or the original peak can
be integrated which is more accurate but less robust.
Next, the peaks are grouped together between the samples using a grouping algorithm.
Again xcms allows an option for this. The first is a fast kernel density estimation algo-
rithm applied to slices of m/z to group the peaks close in retention time. Any areas that
have a high density are selected as groups/features. The other algorithm is called ’nearest’.
This algorithm is a nearest neighbour algorithm. By looking at the whole LC-MS land-
scape across all files/samples any peaks which are close to other peaks in other files are
neighbours. Using a Euclidean distance the peaks are determined to be associated with the
group or not. Figure 1.2 shows how different grouping algorithms can help to better define
the groups. The figure demonstrates how erroneous peaks can be incorporated into the
feature. Both figure 1.2 A&B show that more than the maximum number of samples (21
in this dataset) are in the feature. However, in C using ’nearest’ as the grouping algorithm
a correct feature group is made.
Once these groups have been determined, RT alignment can be performed. XCMS has a
non-linear RT alignment algorithm. It works by finding ’well-behaved peak groups’. These
well behaved peak groups act as anchors in a local regression model (LOESS). This model
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Figure 1.2: The figure demonstrates poor group-
ing. Each plot is a plot of RT and
m/z for a set of group of peaks. Each
peak is shown as a coloured num-
ber, where the colour and number
demonstrates the file/sample which
the peak came from. The box around
the peaks shows the peaks that have
been determined to be the same, a
feature. In A, the peaks have are
unaligned and grouped. The num-
ber of peaks is more than the to-
tal number of samples (21 in this
data). In B, the peaks have been
aligned and grouped using the ker-
nel density algorithm. After align-
ing, the feature is still incorporating
extra peaks. Finally, in C by using a
different grouping algorithm, nearest
a correct feature has been defined.
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allows for a non-linear/segmented fitting and outlier detection which makes the model ro-
bust. Now that the data has been aligned the back filling or ’fillPeaks’ algorithm can be
run to integrate any background or peak that were not identified as previously stated. Fi-
nally, EIC, box plots and a Welches t-test are done to help the user find the most important
feature in the dataset.
1.3.2 Data Preprocessing Software Platforms - NMR
Data extraction software for NMR can be much simpler 1. Since the data is normally only 2
dimensions (ppm and intensity) either binning or signal processing techniques can be used. Also
helping ease the analysis of NMR data is that NMR has a very high analytical reproducibil-
ity [55–58]. This high reproducibility reduces variable shifts between samples, allows data to be
taken from different labs and or instruments and reduces false positives (FP) due to analytical
variation being interpreted as biological variation.
The simplest way to extract the NMR data is to bin (sometimes called bucketing) each spectrum
into thin ppm slices. For each bin, the intensity from the ppm values that are within the bin must
be average in some fashion to produce a single value for the single bin.While some peaks shift
a bit due to pH differences this can actually be information that is kept and can be informative
about the sample set. Once all the spectra are binned a multivariate analysis can be performed
on the data.
One of the advantages of NMR is that identification of metabolites is much simpler than in
LC-MS datasets. With this in mind metabolites can be fitted based on their chemical shifts,
multiplicities and J-couplings to a reference list of compounds. Once all of the peaks that can
be determined are fitted a list of compounds is generated. This list can be used to integrated the
1A limited overview of data preprocessing will be discussed however, this report does not include any NMR
preprocessing and so is simply given as background.
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peaks to find their intensities. One of the popular software platforms to do this is Chenomix NMR
suite [59]. However, this has to be performed manually and is a user intensive task. Recently
a publication by Hao et al used a Bayesian model coupled with a Markov Chain Monte Carlo
(MCMC) algorithm to automate identification and quantification of 1D NMR spectra [60, 61].
The software uses a lookup list of resonance patterns to identify the compounds. The final output
of the software is a fully identified list of compounds with intensities for each sample. However,
due to the high complexity and many possibilities the computational time is high.
Both of these methods have problems. Binning while fast, lowers the resolution of the spec-
tra. This means that potentially two or more peaks can occupy the same bin. With binning the
metabolites have not been identified before analysis and so the multiple peaks for each molecule
can lead to redundant data. However, this can also be viewed as a confirmation that the analy-
sis is correct. The fitting methods normally take a long time and the wrong metabolite can be
fitted to a peak. However, once the fitting is performed and if done correctly then fitting the
data is reduced and metabolites are already identified making direct analysis into pathway analy-
sis possible. Fitting also removes the possibility of finding novel metabolites in the NMR dataset.
1.4 Quality Control
Variation can come from many different sources. These sources of variation can be summed
into two categories, biological and analytical. Biological variation is seen in any collection
biological samples and can be caused from small or big changes in the local environments of
the animal/patient. Analytical variation however, is caused by changes from sample to sample in
the local environment of the instrument. This is due to many reasons such as poorer ionisation
efficiency caused by the sample coating the electrospray needle and skimmer [62], fluctuations
in column chemistry (can be heavily reduced by QC sample equilibrating of the column) [63],
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changes in temperature and fluctuations in nitrogen flow between samples during the run will
change the ionisation efficiency. Variation in m/z measurements can derive from can also come
from temperature changes (in TOF systems), electronic noise and the number of ions hitting the
detector.
In any experiment analytical variation needs to be minimised. While every effort is taken to
do so it is not always possible to completely remove it. Quality Control samples, termed QC
samples [63–65] allow a way to measure this variation These samples are normally injected
every 10−20 samples and at least 5 QC samples should be injected to equilibrate the column [63].
There are many types of QC samples that are used in LC-MS experiments. Some of these are:
• Pooled Samples: The QC sample is a linear combination of the biological samples. The
assumption therefore is that the Biological variation has been removed. By using a linear
combination no dilution effect should be seen for any one sample [62, 64].
• Standard Samples: These are where certain standards that are consistent with the profiled
matrix are used. The standards are used in many ways to help with the normalisation of
the signals and with identification of similar compounds [66, 67].
While typically used with the pooled QC samples the coefficient of variation (CV) value of the
intensity measurement can be calculated for each peak or feature using the QC samples. When
used with the pooled QC sample the CV value can be used as a filter, to remove any feature that
might be too variable in the analytical measurement. If the instrument cannot measure the feature
reliably in the absence of biological variation then the feature is deemed unreliable. Normally the
CV filter is set to remove > 20% CV. The median CV in some datasets can 30% or more. A 30%
CV value is still accepted in LC-MS datasets for untargeted profiling [65, 68]. The median CV
value can be used as a measure of how reproducible the dataset is in terms of analytical variation.
Other methods have been proposed where an internal standard is injected into all of the samples.
However, this can cause ion suppression and consequently remove some of the analytes which
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are being seen. Also when untargeted profiling is being used finding the correct internal standard
is difficult especially when the dealing with unknowns [69, 70].
1.5 Statistical Data Analysis
When all of the data has been extracted and only the robust variables are left the data can be anal-
ysed. There are many different ways to do this and depending upon the needs of the experiment
this can range from a highly complex model to a simple statistical test.
1.5.1 Univariate Statistics
Univariate statistics is defined as assessing one variable/feature at a time independent of the any
other variable/feature. In metabolite profiling this can be particularity useful if there is a known
drug compound which has been metabolised and single metabolites need to be assessed to see
if there were effected by this drug. Univariate statistics can also be very useful as they do not
test the effects of other features only the selected feature. Consequently, the test is not altered
by these other features, in a statistical fashion. Many clinical biomarker tests are performed
with univariate tests. One of the tests which is often used is the Welches t-test. This test is
an adaptation of the Students t-test. They, test the null hypothesis of whether or not the two
distributions means are equal. If the p-value is below the chosen significance level (alpha or α)
then the null hypothesis is rejected.
While this is the most widely used univariate test there are others. Univariate tests can be split
into two main categories:
• Parametric or non-parametric
29
• paired or unpaired
These two main categories of univariate tests are the main assumptions when choosing a test.
The first is simply defining if the data can be assumed to have a defined distribution,parametric
or if there is no defined distribution, non-parametric. The next group is the assumption of how
the data was sampled. If the data was sampled all from the same individual a paired test can be
used whereas if independent sampling were used then an unpaired test should be chosen.
Biological datasets have many hundreds to thousands of variables that need to be tested. This
means that the same test with the same assumptions is being run many times. With any test there
is the possibility of getting false positive (FP) results. A FP result is a result below the cutoff
limit, below α, in the test but truly the null hypothesis should have been accepted. When the
cutoff level of 0.05 (alpha) is chosen the probability of a FP in one test is 0.05. However, this is
in a single test. When many tests are performed, the probability of a FP result is much more than
0.05. Therefore some sort of multiple testing correction needs to be done. The most well known
and rigorous correction is the Bonferroni.
α′ =
α
n
(1.1)
The correction is as shown in equation 1.1, where the n is the number of tests and α is the chosen
level of significance. However, this correction method is very strict and increases the number
of false negatives (FN). Another multiple testing correction termed false discovery rate (FDR)
can reduce the number of FN. The FDR is the expected proportion of false positives among all
discoveries (rejected null hypotheses). Finding the FDR is simple. One of the most popular
FDR approaches is the Benjamini and Hochberg [42,71] approach. In this approach a step down
procedure is used. If the p-values are ranked so that p1 ≤ p2 ... ≤ pi for a total of m tests and an
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FDR rate, δ is chosen then the equation 1.2 can be used to find the significant p-values.
p(i) ≤ δ × i
m
(1.2)
This area is a well research area of statics and there have been newer approaches to the technique.
A procedure by Storey [72] corrects for the false non-discovery rate or positive FDR. The method
uses the distribution of the p-values and how the distribution of real data is different to that of
null tests.
One of the other univariate methods that are often used in metabolomics are the Wilcoxon rank
test. This test uses a ranking of the variables to come up with the test statistic. This test is used
when the data is non-normally distributed and is non-parametric. Equation 1.3 shows how the
test statistic is calculated.
W =
N∑
i=0
sgn(yi − xi) · Ri (1.3) z = W − µw
σw
(1.4)
t =
x¯1 − x¯2√
σ1 + σ2
(1.5)
Here, x and y are the same variables from different classes of sample i and R is the ranks of the
differences of x and y. The statistic W is made by taking the sum of the signed ranks, excluding
any pair of variables where x − y = 0. Once W has been calculated the test statistic can be
transformed to a z statistic. To do so equation 1.4 is used, where σw is the standard deviation of
W and µw is the mean of W. Once the z-score has been found a p-value can be easily calculated
from a normal distribution.
Another common test univariate test used in metabolite profiling is the Welches t-test as seen
in equation 1.5. Here, x1 and x2 are the same variables from two different classes and σ is the
standard deviation from the respective classes. This equation produces a t-statistic like the Stu-
dents t-test. This statistic can then be looked up on tables to find the p-value given the degrees
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of freedom. The Welches t-test is used when the two classes have unequal variances, seen by the
two class σ values rather than the pooled σ of the Students t-test.
Sometimes there are multiple classes that need to be compared at the same time. It is possible to
use a t-test or Wilcoxon rank test on each pair of classes. However, this is time consuming and
increases the number of tests therefore increasing the number of false positives, even though this
can be control. Another way is to use a univariate test that compares multiple classes at once.
The parametric method of doing this is Analysis of Variance (ANOVA). This test statistic is very
popular and has been used classically for design of experiments. It has also been extended to a
multivariate form. With multiple class comparisons the test statistic does not describe which of
the mean levels of the classes is different only that the set of classes are different. To find out
which of the classes mean levels is statistically different a post-hoc test would need to be per-
formed. These post-hoc tests are normally the two-way comparison tests. With Kruskall Wallis,
another multi-class comparison test that is the non-parameteric cousin of ANOVA, post-hoc test
are done with the Wilcoxon rank test. Kruskall-Wallis is an extension of the Wilcoxon rank test
applied to a multiple class scenario. If the test showed that a particular variable was significant
across the multiple classes then a Wilcoxon rank test could be done on all pairs to see which
class was different.
1.5.2 Multivariate Statistics
Multivariate statistics can be very powerful in helping to define a class group. This is because
they use all of the variables, and show how the variables are related to each other. One of the
most well known and common multivariate techniques in metabolomics is principal component
analysis (PCA). Some other multivariate analysis are multiple linear regression, Partial Least
Squares regression and Multivariate analysis of variance2.
2Only PCA will be described in detail as this is the only multivariate method which is used in this report.
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PCA finds linear combinations of variables which explain the highest variation. The model is
made up of multiple principal components. Each component is a description of the variance.
Each component gets an R2 value describing how much of the variance has been explained. The
first principal component describes the most variance. The second component is orthogonal to
the first. The maximum number of principal components is smaller than or equal to the number
of samples −1 or until all 100% of the variance has been explained. Each component is orthog-
onal to the other.
To make sure that the model is predictive and is not simply being driven by a set of outliers, a
predictive error value called the Q2 value can be made. This value can be made by many different
ways however, the most common is by leaving out a set of data or leaving one sample out (LOO).
This is done many times until either a certain number of iterations has been satisfied or there are
no more unique sets of data. For each iteration the left out data is predicted and the compared
to the real data. A value called the predicted residual sum of squares (PRESS) can be made for
the prediction. The value is an error value telling how close the predicted data is to the original.
PRESS can be converted to a Q2 value so that it is on the same scale as the R2 value.
Scaling methods are often used to transform the data matrix into other spaces. This can help
to explain the data and improve the accuracy of the model. PCA is sensitive to scaling methods.
Methods such as univariate scaling give an equal weight to low intensity peaks and high intensity
peaks however, this also has the effect of giving a lot of weight to noise peak in NMR data.
Another popular scaling method is Pareto scaling [73]. This method is able to give low intensity
peaks more weight without greatly enhancing baseline peaks. Scaling can also reduce or remove
the Heteroscedastic noise in the data. Heteroscedastic noise is where each variable has a different
amount of noise associated with it in a multivariate dataset. By changing the scaling of the
original dataset this noise can be reduced [74].
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1.6 Characterisation and Metabolite Databases
Characterisation can be an ambiguous term in metabolite profiling. Here, we use it to further
define both the spectra; to annotate peaks and describe the relationship between peaks and the
processed features in question; characterising these to metabolites. Spectral peaks have many
relationships which can be used to understand them and describe the relationship to a set of
rules. Once processed these peaks become features and need to be explained in terms of bio-
logical metabolites. We look at a few databases which help to translate these peaks into known
metabolites.
1.6.1 Spectral Characterisation
In untargeted metabolite profiling, the most time consuming aspect is to identify metabolites [50].
There are many different paths to getting more information to help to characterise the metabo-
lites. With more information the easier the database lookup becomes. The databases have also
gained more information and have increased the ways to help identify the metabolites with on-
line fragmentation databases and ppm shifts. Figure 1.3 shows a general workflow of finding a
metabolite with the LC-MS platform and the data preprocessing workflow. It should be noted
that this workflow is not always the answer, such methods as ultra high resolution mass spec-
trometry and retention time mapping can also characterise a feature to a metabolite.
Even though metabolite characterisation and identification is easier with NMR datasets (multi-
ple dimensional experiments with 13C, 1H 31P, 15N etc allow good coverage of the practically
any biological molecule) it can still be difficult with a complex sample, such as those used in
metabolomics. One of the methods that helps to identify related peaks is statistical correla-
tion [75]. The peaks from each compound will shift in a coherent way between samples, in both
intensity and ppm. While this ppm shift is not always linear it can be detected with Pearson
correlation. These correlation can then identify the relate peaks which in turn helps to identify
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the compound.
In LC-MS the same correlation technique can also be use to detect isotopologues, adducts
and fragments. Much like NMR, LC-MS produces multiple peaks for the same compound. The
intensity of the isotopologue and adducts will have a linear change with regards to the molecu-
lar ion. This unified change happens due to the various forms of the compound (isotopologues,
adducts and fragments) being formed during ionisation. Therefore, there is a linear relationship
between the intensity of the isotopologue and the adducts3. Using this knowledge the molecular
ion, can be found by relating all of the adducts together. The doubly charged molecular ion,
[M + 2H]2+ ions will have a linear relationship with the doubly charged adducts eg [M + 2Na]2+
and [M + 2K]2+. However, the intensities of the doubly charged adducts will not be linear with
respect to the single charge molecular ion. The other single charged adducts can be worked out
by using a simple lookup table of mass differences.
Once all of the adducts are found and the molecular ion has been identified this m/z can be used
to find the metabolites from a database lookup. Any fragments that have been found in the spec-
trum will provide clues to how the molecule is made up and what are the possible atomic bonds.
1.6.2 Using Databases
Metabolite databases are an essential part of metabolomics. Identification is arguably the most
difficult part of the process. There are many aspects to any database, the ways in which it holds
the relevant information and what the database is customised for, some of these aspects are
discussed below. As the field has grown and identification has remained one of the big challenges
and there has been a need for standard terminology. This has lead to the standards initiative [76–
3 Note that due to the non-linearity of the instrument in certain high or low intensities, the relationship may be non-
linear if outside of the linear range of the instrument. Evidence is shown that the relationship can be detected
using a linear relationship in chapter 4.
35
78]. Sumner et al defined the minimum reporting requirements for metabolomics studies. This
has helped defined the various levels of identification. They are defined as:
• Identified compound - This is where a compound has been identified with a reference
standard
• Putatively annotated compounds - Where a compound has been identified with a reference
library but not side by side with a standard
• Putatively characterised compound classes - Compound has shown a high similarity to a
class of compounds via spectral similarity or chemical properties
• Unknown compounds No known ID to the compound, however it can be verified as a true
signal coming from a chemical entity.
To be able to get to each of these different levels of identification, the databases need to contain
the information to leverage the research. The information can be roughly broken up into some of
the following areas.
Accurate mass
For LC-MS experiments this is essential. Simply having the formula of the molecule
allows the generation of the mono-isotopic mass. The m/z of an unknown can be compared
to this mono-isotopic mass to find out the ppm difference. If the difference is very large
and outside of the specified ppm range for the instrument, then this is suggestive that the
m/z does not match to the compound in the database.
Spectral data
1. Tandem MS - In LC-MS experiments a simple MS spectrum of the compound gives
little extra detail beyond the formula. However, fragmentation spectra from spe-
cialised tandem MS experiments yield not only what atoms are in the molecule but
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also how they are connected. Tandem MS experiments require specialised MS in-
struments that have the ability to isolate a single m/z ion packet and accelerate it into
inert gas, normally Helium or Nitrogen. These spectra need to be collected at sev-
eral different collision energies and can be difficult to compare between instrument
vendors. Figure 1.3 shows how a single statistically significant m/z from an EIC is
selected and a tandem MS experiment produces a MS 2 spectrum. This spectrum is
then search against a library of MS 2 spectra and the corresponding compound can be
found. Some of the databases that have tandem MS data are shown in table 1.1
2. NMR - Most databases that hold NMR spectra have 1D spectra. However, some such
as HMDB have 2D spectra. As table 1.1 shows there are fewer metabolite specific
databases based on NMR. The spectra which are in the databases can be difficult to
match up to the experimental spectra due to the experimental spectra having biolog-
ical matrix peaks that overlap or hide the spectral peaks of the database match. Also
pH shifts in the experimental spectra add another layer of complexity. Much like
the MS databases where multiple fragmentation energies need to be stored, NMR
databases need to have the 1H spectra and the other NMR suitable nuclei. Most
databases also try to have the 13C spectra of each entry.
Annotated experimental spectra
Annotation of the spectra in the database can be difficult, but yields a high volume of
information on each spectrum. In MS databases this means that the specific fragment is
listed for each peak. In NMR databases this means that the chemical moiety that makes
that chemical shift is listed. Sometimes this can be done automatically by working with
specialised software. This has been used in many MS based databases where the compound
is fragmented in-silco to generate every possible fragment and is then match back to the
spectra [79].
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Figure 1.3: A general workflow for mass spectrometry based metabolite profiling. The figure
shows the sample being injected into the mass spectrometer and then xcms being used
for the data extraction. A feature is detected that differentiates the classes. Since the
compound is unknown accurate tandem MS is performed to get the fragmentation
pattern of the compound. This spectrum is then searched against a database and a
characterised compound is identified. Figure altered from Benton et al [50]
Metabolite characterisation
Metabolite characterisation has become very important in the past few years of the field as
the biology behind each metabolite has become an essential part of the research. A descrip-
tion of which pathway the metabolite is formed or is used in can help in the understanding
of the underlying biology and consequently the disease.
The table 1.1 shows some of the most popular databases in metabolomics. Using the resources
from these databases and the tools to help characterise the spectra from the raw data, metabolite
identification has become easier. With more tools [50,80], algorithms [81] and new experimental
methods identification will become easier. As metabolite ID becomes a simple single step pro-
cess other more complex experiments will yield more information about the underlying biology
happening in the studied system. Some of these experiments such as temporal metabolic profil-
ing have already started to become more popular. The latest tools, such as complex correlation
networks and temporal profiling help to find the metabolites that explain the biology in the stud-
ied system.
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Database Speciality Interface Accurate
Mass
Outside
Links
MS/MS
Data
Spectral
NMR
Entries
Metlin Endogenous
Metabolites
web x x x 76,064
HMDB Metabolites web x x x x 40,437
KEGG Pathways web x x 16,980
ChemSpider All Chemical web x x x 28M (all entries)
KnapSack Plant
Metabo-
lites
Java app. x x 50,897
MassBank Metabolites web x x x 39,407
LipidMaps Lipids web x x x 37,127
NMRShiftDB NMR data web x x 41,921
Table 1.1: Metabolite databases and some of the relevant information [82–88].
1.7 Correlation Networks
Networks are always an interesting area in biology, especially with metabolites. Networks have
the ability to infer a relationship between two variables or nodes. When metabolites are con-
nected in the network this pair may have a relationship. The connection can be from any met-
ric, linear correlation [89–91], mutual information [92–94] or even complex bayesian estima-
tors [95]. The inferred relationship between metabolites can be a pathway, signalling event or
any process that has affected the metabolites with similar dynamics. However, often more data is
needed than simple correlations to make a biologically relevant network [89]. Yet, these simple
correlations networks can give a large amount of information in understanding the apparent and
underlying relationship between metabolites that is not seen when only considering mean levels.
Also, correlation networks allow for a ’fingerprint’ description of the state of the system which
is different from ’fingerprint’ analysis at the mean level.
In networks the relationship between the two variables(nodes) is called an edge. Any statistic can
be used to make the edge. One of the most popular statistics is correlation. Linear correlations
are computationally fast and intuitive. Unlike other metrics, especially non linear metrics, they
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are able to fit the data with fewer data points than many other statistics. However, correlation
can be effected by outliers without the use of a robust correlation method. As previously stated
correlations can be very useful in characterising the raw spectra and relating peak or spectral
shifts. When the networks are made there needs to be a way to describe the network. Thus, there
is a special area of statistics dedicated to describing the network.
1.7.1 Network Statistics
Networks can be difficult to describe. For this reason there are special statistics that help to
describe how a network functions, what it looks like and even how the network can react when it
is altered. These statistics mean that different networks can be compared against each other using
these metrics to understand the differences between the networks. Some of the popular network
statistics are:
• Degree - Defined as the number of edges connecting a specific node. This is one of the
simplest forms of network statistics.
2E =
∑
υ∈V
deg(υ) (1.6)
In equation 1.6, E is the total number of edges in the network, deg(υ) is the degree of a
single node4. The sum of all degrees in the network is double the total number of edges
in the network. The degree of the network can be either a local or global statistic when
averaged among all nodes. The global degree average can be very informative about a
network. A network with a high global degree average means that the network is highly
connected. The distribution of degree frequency can also be useful in understanding the
structure of the network.
4nodes can also be called a vertex
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• Shortest Path Length - This is the length of the shortest path between two specified nodes.
There can also be a mean shortest path length for the network, which is the average of the
shortest path between any two nodes in the network.
1. Mean Path length - This is the average number of edges between any two nodes.
For an undirected network it can be defined as seen in equation 1.7. Where υi and
υ j denote different nodes within a network and n is the number of nodes within the
network.
lg =
1
n × (n − 1) ×
∑
i, j
deg(υi, υ j) (1.7)
• Betweenness Centrally - is a centrality measurement that quantifies how many times a
node is used in connecting two nodes along the shortest path. Explained in another way
nodes that are nodes that are used in a shortest path between any two random nodes in a
network will have a high betweenness. This can be shown as in equation 1.8 where συi, j is
the total number of shorest paths between all pairs of nodes in the network and συi, j(υ) is
the number of shortest paths that go through node υ. The sum is taken where node i cannot
be the node in question.
CB(υ) =
∑
υi,υ j,t∈V
συi, j(υ)
συi, j
(1.8)
Many of these statistics are altered when the graph is considered as a directed network. Di-
rected networks state a direction of flow or which node affects which in the connection. Di-
rectionality is often seen in temporal networks. One of the statistics that is affected is the be-
tweenness centrality. If there is a direction to the edges then the shortest path may need more
edges to connect the nodes or it may not be possible to connect the nodes. Betweenness is more
than just a measure of the connectivity of the network. It is a descriptor of how well the net-
work is connected and can adjust or divert flow. If a highly central node is removed then the
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node betweenness will increase substantially. The statistics can be defined in either a directed or
undirected network, here we have defined them in an undirected network.
1.8 Temporal Analysis
Temporal data is starting to be more common in metabolomics. This data has the ability to
explain the dynamics of the underlying biology of the studied system. The aim of temporal data
profiling is to be able to capture the events that are altering or affecting the system. Slowing the
production of temporal metabolite profiling data has been a list of different issues as outlined
below.
1. Difficulty in generating long (> 10 time points) time series
2. Unknown required sampling rate. Prior to recording the experimental data the required
sampling frequency to observe the desired biological effect is unknown. However, this
can normally be guessed on the magnitude of the scale which is needed However, this
generates a large problem of either under-sampling or over-sampling. Under-sampling
results in missing the effect, where as over sampling is expensive.
3. Variation between individuals. The variation in the experiment between individuals due
to the speed of the response or timing of metabolite events, may not always be due to the
desired effect. Consequently, this increases the amount of variation and dilutes the desired
effect or may even make the effect undetectable.
However, once these issues have been over come and the data is collected analysis of the data
can also be problematic. The data can be analysed for many different aims such as; temporal
relationship between metabolites, prediction of future time points and the dynamics of a single
metabolite.
With the extra level of complexity in the data it requires special software/algorithms. Temporal
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data algorithms use the temporal order to understand the dynamics. These algorithms make a
model of the time series. To date few temporal metabolite profiling algorithms have been pub-
lished [96]. Some of the above reasons, with the difficulty to generate the data, has hindered the
development of these algorithm but also the high dependancy of the data. Each time point can-
not simply be taken as an independent analysis, as each time point is dependant on the previous
time point, the memory of the system. Added to this is the fact that many of the variables are
correlated to each other. Some of the classical time series analysis methods are able to explain
the memory of the system. However, as they are univariate methods they only consider one tem-
poral profile at a time and consequently do not use or explain the dependant nature of temporal
multivariate datasets.
1.8.1 Temporal Algorithms
Classic Algorithms
Classically, time series has been a univariable analysis trying to understand how the variable
tracks through time. There has been a lot of development in financial data with tracking stocks
and describing the patterns. These methods can describe if a time series is cyclic, if the time
series has a repeating pattern, how long the memory of the time series is. Some of the models
that can answer these questions are:
• Moving Average Models (MA) - This model is essentially a smoothing filter for the time
series. It assume that the function is based around a centre mean. The model updates the
average as each time point is assed.
• AutoRegressive Models (AR) - These models use the previous time points for the output
variable. The model uses regression on itself to predict future time points, therefore the
output is a linearly dependent upon the previous time points.
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• AutoRegressive Moving Average Models (ARMA) - Incorporates both a moving average
and an auto regressive portion to the model. These models require stationary data ie data
that has a uniform mean.
• AutoRegressive Integrated Moving Average Model (ARIMA) - These models add an extra
parameter in (d) to allow for time series that are non-stationary.
• Vector forms - The above models can be generalised to multivariate models, such as Vector
Autoregression Moving-Average models. However, these models are less widely used.
The vector forms require all the variables to be co-stationary which is rarely the case in
metabolite data and require many time points to have a satisfactory model.
All these methods have the draw back that they require stationary data (the mean of the data is
roughly stable) and are linear methods. Models such as the ARMA model, which is very popular,
can produce useful autocorrelaiton function plots (correlograms) that give information about the
memory in the data. They have been used for the basis of many specific biological methods.
Due to the auto-regressive nature of these methods they require many time points to be able to
generate a stable model. This means that they are not well suited for the median to low time
point datasets of temporal metabolite profiling.
Temporal Specific Metabolite Profiling Algorithms
All of these algorithms use the order of the temporal data to understand the dynamics. Some
of the simplest are the SME models [97]. This model will be discussed in more detail later in
chapter 5. However, briefly this method uses spline fitting to fit the time series for one metabolite
at a time in each set of classes. A median fit is then found for each metabolite and class. The
median fits can then be compared between the classes using a modified t-test. Again this method
compares only one metabolite at a time.
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When a multivariate method is needed, such methods as PCA and PLS are often used. PLS
models can be helpful in describing temporal data and even predicting future states. Wold et al.
described a method where batches of chemical pharmaceutical processes were defined as either
good or bad and the method could describe the next batch. In this model a 3D matrix was setup
where the time points where columns and the batches were rows [98]. The multivariate models
can also be used where the output of one model makes the input for the next. For instance a
simple PCA can be performed on the data as normal. Then using the top components from the
PCA model the scores for each component can be extracted. Using these scores they are then
lagged against each other [99]. This method allows an exploration of the latent structures in the
time series and the states in which the time series moves.
One of the areas of research which is gaining in publications is to build networks and then analyse
the differences between the networks or the differences between the states [100–102]. However,
there is a lot of difficulty in building an accurate network which describes the non-linearity and
dynamics of metabolite networks. Many of these analysis try to describe the non-linearity of the
metabolite networks to accurately describe and hopefully discover new pathways and signally
networks. The effort is also seen directed towards flux balance analysis models [103–105].
Many of the current methods do describe a state or identify a new pathway. As discussed the
common practice of metabolite profiling is to find a metabolite which is either responsible for
the the change or is its concentration level is changing in response to the stimuli. New meth-
ods are needed to be able to look at differences in temporal relationships within and between
metabolites. Network analysis has the advantage that it can find the relationships between the
metabolites and they are flexible to be able to do this in both a temporal fashion and compare
between classes.
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1.9 Analysis Framework
Here, we propose a possible framework for the analysis of high throughput omics data. Fig-
ure 1.4 shows this framework and explains the different levels data analysis. We discuss this
framework in terms of metabolite profiling. Level 1 is a comparison between the classes using a
mean or median concentration. In figure 1.4 this is seen as two box plots that have different me-
dian levels the red class having a lower median level that the blue class. This is the conventional
methodology and many studies do not go past this level.
The second level can be a comparison between classes as well but uses the covariance between
metabolites to understand the data at a deeper level. In the figure, this is given as a simple
no class comparison but shows a correlation network to describe the connections between the
nodes. Some nodes are not connected and so have no relationship to other nodes at this level.
These methods do not necessarily involve network depictions but involve relating one feature
(variable) to another. Methods at this level would be PCA, correlation networks and factor anal-
ysis to name a few. Some methods such as PCA can be used in a level 1 capacity where they
are simply used to find the mean level difference between two groups. However, they can also
be used to understand the relationship between the features from the loading plots. As already
stated correlation structures can yield a lot of information more than just pathways but also inter-
actions beyond simple neighbouring metabolites [106]. In general term correlations do not have
to be Pearson correlations or other correlations but can also be non-linear metrics such as mutual
information. However, any metric that can determine a relationship between two variables is at
this second level analysis. There has been a lot of interest in this area such as Opgen-Rhein et al.
work. that looked at genetic networks using correlation structures and then reducing them using
partial correlations [90]. This level is extendable to other areas outside of metabolite profiling
and data for genetic studies can be very different, not only its origin but also in the relationships
between the pairs. This level analysis will be used to help understand higher orders of repro-
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Figure 1.4: Proposed analysis Framework. This figure shows three levels of high throughput
analysis. In 1 is the mean/median intensity level class comparison, between red and
blue. The second level shows a relationship between the variables, depicted here by
a network analysis of various nodes. Some of the nodes are connected and so share
a relationship. This second level is only with static data and does not include any
dynamics. Finally, the third level (3) is a demonstration of the change of the relation-
ships between the variables. Each new network is a new lag (∆t). The relationship
between the variable is lagged by a different amount of time for each network.
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ducibility discussed later.
Finally, the third level is a dynamic level of temporal analysis. This is a deeper level of anal-
ysis with the hope of deeper understanding of the variable. In figure 1.4-3, this is demonstrated
by the networks at different time lags. Each network has been independently generated using
a metric such as correlation. The relationship between the variables at level 3 is performed by
using the same metric as in level 2 but lagging the variable by a specific time lag. If the two
variables are connected in the network at this level then there is a pattern that is seen to happen
at this lag. The pattern is determined by the metric used. Level 3 can be performed in multiple
ways when different classes are used. Depicted here is a simple single class analysis. As will be
discussed later in chapter 5 the lagged networks can be made independently for each class and
later compared. Level 3 does not strictly require network depictions but can be helped by the use
of these structures in showing the flow between one state and the next as the time lag progresses.
1.10 Aim of Thesis
In this chapter, we have outlined some of the concepts and background that will be used in the
following chapters. The aims of the thesis are to
1. Develop a computational method to improve quality of UPLC-MS data in metabolite pro-
filing studies.
2. Assess the analytical reproducibility of UPLC-TOF-MS for urinary metabolomics both
within and between laboratories.
3. Determine the ability of statistical correlation to identify structurally related signals in LC-
MS metabolomics data.
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4. Show that the analytical procedures introduce their own correlations and to develop a
method to filter out these artefacts.
5. Develop new methods to find temporal metabolic biomarkers using differences in through-
time correlaitons
We show that these methods and research, are novel and important to the field of metabolite
profiling. The wider area of high throughput techniques and mass spectrometry based sciences
are impacted by this research.
49
2 Correction of Mass Calibration Gaps in
Liquid Chromatography −Mass
Spectrometry Metabolomics Data
2.1 Introduction
Liquid chromatography-mass spectrometry (LC-MS) has become a widely used methodology in
metabolomics. Profiles generated by this method are highly complex and many software pack-
ages have been designed to analyse this data (e.g. mzMine, XCMS [46, 49]). These typically
employ a peak-picking algorithm for selection of peaks and removal of noise. Peaks are then
matched between samples, correcting small drifts in retention time (RT) and the final result is a
table of the integrated intensities of each peak in each sample.
An important goal in LC-MS experiments is the accurate measurement of the mass to charge
ratio (m/z). Usually a mass calibration method is used throughout the experiment to keep the
m/z deviation within the desired range. MS manufacturers employ different methods to calibrate
their instruments. Some manufacturers use a switching method, which regularly changes the MS
input between the analyte and a standard reference [107]. Switching the flow in this way can
avoid the problem of ionisation suppression encountered with continuous flow methods. How-
ever, changing the flow to the lock mass spray temporarily stops the analyte from being detected,
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resulting in gaps in analyte data. These lock mass gaps can cause a single peak to be split into
several smaller peaks (figure 2.1), confusing the process of peak matching. Even if the peak is
detected correctly, the true intensity will be underestimated due to the gap. The situation is fur-
ther exacerbated by RT drifts across samples, which will cause the position of the gap within the
peak to shift. The peak detection, multiplicity and loss in intensity will thus vary depending on
where the gap is in the peak. This variability can lead to both false positives and false negatives
in peak detection, and inaccurate intensity estimation. While most vendor software is presumed
to take account of such elements of MS design, this is not true of widely used and community
supported open source software for LC-MS data processing. We have developed a method which
recovers the lost intensity by filling in the gap. The method greatly reduces errors in peak detec-
tion, matching and intensity estimation and is freely available as a built-in function stitch [108],
for the XCMS package.
2.2 Methods
2.2.1 Analytical Data and Processing
Caenorhabditis elegans were grown under standard conditions and snap frozen upon harvesting.
The pellets were extracted in 80 % ice cold MeOH using a FastPrep bead beater (Precellys 24)
for 40 seconds at a speed of 6.5 m/s. After centrifuging the supernatant was collected for analy-
sis, the pellet re-extracted and the joined extracts dried prior to analysis.
10µl of Caenorhabditis elegans extract was separated on a Waters ACQUITY UPLC system us-
ing an HSS T3 column (2.1 x 100mm, 1.7µm) (Waters Corporation, Milford, MA). A 30 min
water to acetronitrile linear gradient was used with a flow rate of 500 µl.min−1. All solvents were
HPLC grade (ACN: Fluka, H20: Romil Ltd). Detection was performed on a Waters LCT Premier
ToF mass spectrometer. The sample was run twice, once with a lock mass interval (LMI) of 50
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scans and once with an LMI of 1000 scans. The scan range was set to 50-1000 m/z and a scan
time of 0.2 s and an inter-scan delay of 0.01 s. The majority of peak widths were in the range 2-20
s. Data was converted to mzXML using MassWolf (version 4.3.1). Each dataset was processed
using XCMS (version 1.23.1). A third dataset was generated from the LMI50, by correcting the
lock mass gaps using the new stitch method. These were then processed using the centWave [48]
peak picker on all three datasets. Parameters were peakwidth of 2 − 20 seconds and snthresh of
5. Data was then grouped using mzwid = 0.05; other parameters were set at default values.
2.2.2 Gap Filling Algorithm
The basic idea of the algorithm is to use the nearest available analyte scan to fill the gap. More
precisely, if the location of the gap is from scan n to scan n+k, then the algorithm uses scan n− 1
to fill the first half of the gap and scan n+k+1 to fill the second half of the gap. If the gap length
is odd, the middle scan is filled using scan n − 1. The algorithm requires three input parameters
which are all readily available in the vendor software. These are: the scan number of the first
gap, the lock mass interval (LMI, the time between gaps) and the length of each gap (default 2
scans). Despite its simplicity, this algorithm is very effective at correcting lock mass gaps and
requires minimal user input.
2.3 Results
To test the method, data was acquired for a single sample at two different LMIs. A first acqui-
sition at an LMI of 1000 scans (giving a total of 3 lock mass scans over the entire acquisition)
gave a data set where few peaks would be affected by lock mass gaps. This approximates data
unaffected by the lock mass gap problem. A second acquisition with an LMI of 50 scans (71
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lock mass scans in total) was chosen to correspond to a typical metabolomics protocol. We then
compared the XCMS output for the LMI 50 data with and without correction with the LMI 1000
data without correction.
2.3.1 Corrected Intensity of Single Peaks
To illustrate the success of the method we extracted two example peaks from the data (figure 2.1).
The first peak (m/z=307.08, RT=126 s) demonstrates how the correction algorithm improves peak
detection. The bottom panel of the figure, plotted in black, clearly shows two scans missing due
to lock mass acquisition; these are corrected (shown in red) resulting in a peak with very similar
shape and intensity to that in the LMI 1000 data (top panel). This peak is detected by the soft-
ware in the LMI 1000 and LMI 50 corrected data, but not in the uncorrected LMI 50 data. In
the second example the peak (m/z=308.08, RT=42s) is detected in all three datasets. However,
in the uncorrected LMI50 the peak is much shorter, 3s compared to 5s in the LMI1000 and the
corrected LMI50. The gap effectively leads to a shorter peak and this reduces the intensity es-
timate by 21% compared to the undamaged LMI1000 data (LMI50 intensity = 3146, LMI1000
intensity = 3987). Applying gap correction results in an intensity estimate just 1% higher than
the LMI1000 data (LMI50 corrected intensity = 4030).
Other peaks were also checked to confirm that the algorithm was working correctly all of the
peaks. Figure 2.2 shows a few example of extracted ion chromatograms (EICs) from the raw data
for each peak group. These can be used to view the raw data and confirm that the algorithm has
worked as expected. For the vast majority of the EICs it can be seen that where there is a gap, the
correction method has successfully corrected for the lost intensity and reformed the peak shape.
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Figure 2.1: EICs of peak without lock mass gaps and with lock mass gaps. The red line demon-
strates the filled in lock mass gap area. The EICs in the left hand column with gaps
were originally not detected by the peak detector. The EICs on the right hand col-
umn were detected but with decreased intensity. The new integrated peak area is also
shown in red.
2.3.2 Corrected Global Intensity of Detected Peaks
Many peak detection algorithms use the shape of the peak to help identify it. With the cor-
rection method, this shape is recovered, and more peaks are found. Using the same parameter
settings 2784 peaks were detected in the LMI1000 data, while only 2625 peaks were detected
in the LMI50 data, a decrease of 6%. In the LMI50 corrected data 2869 peaks were found, a
gain of 3% over the LMI1000 data. After grouping, 2625 peak groups were matched between
the three datasets. Extracted ion chromatograms were visually inspected, confirming successful
gap correction. The correction method brought the global intensity distribution closer to the un-
damaged LMI1000 data. The median intensity dropped from 772 in the LMI1000 data to 700
in the LMI50 data (a 9% reduction) but was recovered with the correction method to 775 in the
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(a) EIC (b) EIC
Figure 2.2: Both of the peaks are affected by the gaps. Each of the three peaks groups are shown
where the LMI 1000 is not affected and then the LMI 50 uncorrected and corrected.
These peaks are examples of where the correction algorithm would correct for lost
intensity
corrected LMI50 data (0.4% difference from the LMI1000 data).
To examine the difference between the LMI 50 corrected and uncorrected data sets as com-
pared to the LMI 1000 dataset a subgroup of peaks that were eluting at the same time as lock
mass acquisition was needed. This was necessary as the LMI 1000, although having very few
lock mass gaps, was a separate run and therefore had slightly different intensities and peak inte-
gration ranges to the LMI50 data. To identify peaks, where a gap was present in the peak inte-
gration range, EICs were manually inspected, two such examples of the identified peaks can be
seen in figure 2.2. The 300 peaks with the lowest m/z were evaluated, resulting in 78 peaks where
correction had occurred. The fractional difference in intensity between the pairs of data sets for
each group was calculated using equation 2.1 & 2.2. The fractional difference in intensity be-
tween the LMI50 and LMI1000 data, was computed for both uncorrected ( fc) and corrected ( fc)
data for both gapped and non-gapped peaks. Gap correction resulted in a distribution for gapped
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peaks much closer to that for non-gapped peaks than for uncorrected data (median fu = −6.73 &
3.26 and fc = 4.80 & 3.13 for gapped & non-gapped peaks respectively).
fc =
(LMI50corrected − LMI1000)
LMI1000
∗ 100 (2.1)
fu =
(LMI50uncorrected − LMI1000)
LMI1000
∗ 100 (2.2)
Figure 2.3: A cumulative distribution plot of the fractional corrected fc and uncorrected fu with
and without gaps. The fc no gaps in blue and the fu no gaps in green are not affected
by the gaps and are the expected fractional distribution. However, the red fu gaps are
the integrated peaks that are affected by the gaps but have not been corrected. The
black line is the fc gaps which has been corrected and is much closer to the expected
fractional distribution.
Figure 2.3 shows the cumulative distribution of fu and fc for each subgroup: peaks with gaps
and peaks without gaps. The corrected and uncorrected distributions (blue and green respec-
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tively) for non-gapped peaks are virtually identical as expected. However, the corrected gapped
peaks distribution (black) is very different from the uncorrected gapped peaks distribution and
is much closer to the non-gapped peaks distribution. This demonstrates both the major damage
caused by the lock mass gaps and the considerable improvement obtained by the correction al-
gorithm.
2.3.3 Other Software Comparison
The software mzMine [46, 47] is a widely used LC-MS data processing package. We were
not able to find any mention of gap correction methods in the documentation for mzMine and
therefore assume that the software is not explicitly designed to account for such defects. As a
comparison, the LMI 50 uncorrected and LMI 1000 data were run in mzMine to investigate how
other widely used software performs with lock mass gap damaged data. Both datasets were peak
picked using the same parameter settings.
Parameter settings were as follows: Peak picking: centroid, noise level: 10, minimum time
span: 5 seconds. Peak deconvolution using baseline, minimum duration 5 seconds. All other
parameters were kept at default values.
Using mzMine in this way, 2545 peaks were detected in the LMI1000 data but only 1453 peaks
were detected in the LMI50 data. It seems that the lock mass gaps have altered the raw data so
much that 43% of the peaks are lost. Although it was not possible for us to exhaustively optimize
peak detection parameters it would be expected that the same sample would have similar numbers
of detected peaks in two consecutive runs. It is therefore clear that the lock mass acquisition is
strongly affecting the analyte data in a way that, as expected, is not compensated for by the
mzMine software.
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2.4 Conclusion
The stitch function allows peak detection algorithms to accurately find and integrate each peak.
We note that the method is generic and can be applied to data derived from any LC-MS experi-
ment, for example in metabolomics or proteomics. We have implemented the algorithm within
XCMS [49], one of the most widely used freely available LC-MS data processing packages.
The stitch function allows more reliable data and a great confidence that the result is TP. The
stitch function has been used for all of the following chapters. This means that the peak detec-
tion is more reliable to find the peaks thereby removing FN in peak detection. In summary, our
gap correction method allows LC-MS data acquired with lock mass gaps to be analysed with a
higher degree of accuracy and confidence than currently possible.
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3 Inter and Intra Laboratory
Reproducibility of Liquid
Chromatography-Mass Spectrometry a
COMET Study
3.1 Introduction
Metabolic profiling has become a key component of the modern toolbox at the disposal of scien-
tists investigating the integrated function of biological systems and gene environmental interac-
tions [109]. Metabolic profiles characterise the global metabolic state of the system by assaying,
without pre-selection, the levels of small molecule metabolites in a biological sample, for exam-
ple a biofluid or tissue extract. The approach has yielded new insights across fields as diverse
as functional genomics, toxicology, molecular epidemiology and clinical studies. The increasing
impact of metabolic profiling has reinforced the need for stringent quality control (QC) pro-
cedures and measurements of reproducibility. This information is of interest both to research
scientists and regulatory agencies across the world.
Liquid Chromatography hyphenated to Mass Spectrometry (LC-MS) has become a key technol-
ogy for metabolic profiling, because of its ability to detect hundreds to thousands of metabo-
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lites with wide ranging chemistries from a single sample in a few minutes with minimal sample
preparation. The power of the method has been augmented by the advent of ultra performance
systems (UPLC-MS) [110], which achieve a higher resolution and sensitivity than conventional
chromatography. While the other key technology for metabolic profiling, Nuclear Magnetic
Resonance (NMR) spectroscopy has been shown to be highly stable and reproducible [56–58],
this has been harder to achieve in practice using LC-MS. Traditional QC protocols for LC-MS,
such as monitoring stable isotope labeled analogues of the analytes of interest, cannot be used
in untargeted metabolic profiling since the analytes are unknown a priori [111]. An alternative
approach is to use a biological QC sample, comprised of a representative pool of the analytical
samples, which is injected frequently throughout the analytical run and monitored for changes in
spectrometer response. Several studies have examined within-lab repeatability of the technology
using this approach and have found excellent repeatability of mass, retention time and intensi-
ties [63, 111–113]. Notably, for a large proportion of metabolites, these within-lab figures com-
plied with FDA guidelines on acceptable reproducibility for regulatory acceptance. However, to
date there have been no studies examining the between-day and between-lab reproducibility of
LC-MS for urinary metabolic profiling.
To address this need, we have conducted a large inter-laboratory reproducibility study for UPLC-
MS metabolic profiling. The study was conducted within the framework of the second Con-
sortium for Metabonomic Toxicology (COMET-2) an academic collaboration between Imperial
College London, four pharmaceutical companies and two instrument manufacturers. We aim
to assess within-run, within-lab (between-day) and between-lab reproducibility of UPLC-MS
for metabolic profiling of urine. To assess reproducibility of both known compounds and the
much larger set of unknowns typically assayed in metabolic profile experiments, the design in-
corporated a set of stable isotope labeled standard compounds spiked into normal human urine
samples. To gauge linearity of response within a complex urinary background matrix, the sam-
ples were subject to a standard dilution series. A more detailed description of the experimental
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design is given in the methods section. Analysis of the unknown signals is left to later work;
here we focus on the standard compounds and how they inform about within and between lab
reproducibility of UPLC-MS for urinary metabolic profiling.
3.2 Methods
3.2.1 Experimental Design and Sample Preparation
The experimental design comprised a Standards Dilution Series (SDS) for system suitability as-
sessment and a Standards in Urine Dilution Series (SUDS) to assess reproducibility. The SDS
samples consisted of standard compounds in water, whereas the SUDS comprised the same stan-
dards spiked into a pooled urine sample collected from 3 healthy volunteers and mixed in equal
proportions. Fourteen metabolites commonly observed in human urine were chosen as standard
compounds and obtained in stable isotope (2H or 13C) labeled forms. A full list of the compounds
chosen is seen in table 3.1. We note that deuterium exchange can complicate quantitation of 2H
labeled compounds. However, we found no systematic difference between the reproducibility of
2H or 13C labeled compounds, suggesting this was not a problem in our study. All samples were
prepared in a single batch at Imperial College London.
All reagents including LC-MS grade water, acetonitrile with pre-added 0.1% formic acid, and
standard compounds were obtained from Sigma Aldrich (Gillingham, UK). Columns and max-
imum recovery vials were donated by Waters Corporation (Milford, USA). The urine samples
were treated with sodium azide (at 0.1 g per 100 ml of urine) and filtered at 0.2 micron to remove
particulates and cells. Stock mixtures of the standards (1mg/ml) were prepared, and diluted to a
working concentration of 10µg/ml per standard. Similarly the standard mixture was spiked into
the pooled urine at a similar concentration. These stock solutions were subject to four two-fold
dilutions resulting in dilutions of 1, 1/2, 1/4, 1/8, 1/16. These dilutions are identified as SDS1
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or SUDS1 for the starting dilution then sequentially as SDS2, SUDS2 until SDS5 and SUDS5
for the most diluted sample. The SDS samples were employed as a system suitability check to
determine whether a given run was to be accepted to the study (see below). Each participating
laboratory received two identical sample batches to accommodate positive and negative mode
analysis. Each batch was further divided into two phases to assess within-lab reproducibility. In
phase 1, a full SUDS was run. In phase 2, run at least one week after phase 1, replicate aliquots
of SUDS 1, 3 and 5 were run. To facilitate handling and storage the four batch / phase combi-
nations were packed in 4 separate boxes and shipped on dry ice to the participating laboratories.
Each laboratory recieved the same solvents and column.
3.2.2 UP-LC-MS Analysis
In each lab, samples were analysed using a Waters R©(UPLC) chromatography system connected
to a LCT Premier TOF mass spectrometer (Waters MicroMass, UK) with electrospray ionisation
(ESI). The same batch of C18 Acquity (2.1 x 100mm 1.7µm) columns (Waters) was distributed to
each laboratory. The same chromatographic gradient was used in all laboratories, over 14 min,
with mobile phases A (water, 0.1% formic acid) and B (acetonitrile, 0.1% formic acid). The
gradient is summarised as follows: 0 min 100% A, 0% B; 4 min 80% A, 20% B; 9 min 0% A,
100% B; 11 min 0% A 100% B; 12 min 100% A, 0% B; 14 min 100% A, 0 % B. The flow rate
was 0.5ml/min and an injection volume of 5µl was used. The mass spectrometer was set to scan
from 85-1000 in mass to charge ratio (m/z), calibrated with sodium formate. Sample temperature
was maintained at 4◦C and column temperature at 40◦C. To allow for differing MS response,
each lab optimised the individual MS conditions separately (e.g. cone and capillary voltage,
desolvation temperature and gas flows, see table 7.2). Technical replication was achieved by
repeated injections from the same vial and this was performed 10 times for SUDS 1, 3 and 5 and
3 times for SUDS 2 and 4. A randomised run order was chosen, ensuring that it was orthogonal to
the dilution factors of both SUDS and SDS, to avoid systematic bias resulting from instrumental
62
drift. The same run order was used for each mode and in each laboratory. Data were sent back
to Imperial College in raw format.
3.2.3 Data Analysis
These data were converted to mzXML format using massWolf (SPC tools, Institute for Systems
Biology, Seattle, WA, USA). The files were grouped according to dilution series (SUDS/SDS),
ionisation mode (+/-) and laboratory (A-C). XCMS [49] (version 1.23.3) was used to process
each dataset separately. Files were processed with gap filling [108] and the following parame-
ters: peak picking method = centWave, peakwidth 2-20 sec; grouping bw/bandwidth of 30 sec,
mzwid= 0.07; retcor missing n2 extra maximum of 3, span maximum 0.7. The retention time
alignment was iteratively processed until a global drift below 2 s was observed using the loess
method. The second grouping was dependent on ’retcor’ and was taken as the global retention
time drift. The standard compound signals were identified in the XCMS output table using an
in-house adduct finder script written in R. This script used estimated retention times based on
a pilot study using an identical experimental set-up (data not shown). The adduct finder used a
comprehensive list of regularly observed adduct forms, chosen from the literature [114] and the
R package CAMERA [51]. The list is seen in table 7.1. The masses of each adduct was added
or subtracted from the expected mass of each compound in positive and negative mode, respec-
tively. Mass windows of 20 ppm and retention time (RT) windows of ±20 s, around the values
estimated from a pilot study seen in table 3.1, were used to find the standard compound adducts.
The pilot study confirmed that, as expected all 14 compounds ionised in positive mode, and 10
ionised in negative mode. The adduct finder detections were inspected manually using extracted
ion chromatograms (EIC) to confirm the presence of a peak. We analysed the performance of the
adduct finder to assess the likelihood of false identifications of the standard compounds.
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Standard Formula Accurate MW RT POS ION NEG ION
dimethylglycine-d6 C4H9NO2 109.1010 0.5200 Y N
L-DOPA-ring-d3 C9H11NO4 200.0877 1.0400 Y Y
DL-methionine- 13C C5H11NO2S 150.0545 1.0400 Y Y
acetylcarnitine-d3 C9H17NO4 206.1347 1.0900 Y N
nicotinamide-d4 C6H6N2O 126.0731 1.2400 Y N
dopamine-d4 C8H11NO2 157.1041 1.3100 Y Y
Succinic acid-d4 C4H6O4 122.0517 1.4500 Y Y
DL-leucine-d3 C6H13NO2 134.1135 1.6600 Y Y
Glutaric acid-d4 C5H8O4 136.0674 1.9000 Y Y
DL-phenylalanine-13C C9H11NO2 166.0824 2.2500 Y Y
Adipic acid-d8 C6H10O4 154.1082 2.5300 Y Y
tryptamine-d4 C10H12N2 164.1252 3.1900 Y N
Heptanedioic acid-d4 C7H12O4 164.0987 3.4000 Y Y
Hippuric acid-d2 C9H9NO3 181.0708 3.4000 Y Y
Table 3.1: The isotopically labeled standards ordered by retention times with accurate masses,
expected retention times (calculated from the pilot study) and whether they should
ionise in positive or negative mode.
3.2.4 Performance Analysis of the Adduct Finder
The reproducibility analysis depends heavily on the ability to automatically identify the standard
compounds and their adducts in the XCMS output. With low numbers of samples, this can
be performed manually. However, this study incorporated 81 samples analysed in two modes
across three labs, with 14 labeled standards and a possible 23 different adducts. This detection of
the resulting 156492 possible unique ions could not therefore be verified manually and thus an
automated adduct finder script was developed for this purpose. To quantify the false positive rate
of the adduct finder, three datasets were tested in which none of the labeled standard compounds
used in this study should be present. The datasets were as follows: an HPLC-TOF-MS human
plasma dataset, with 2368 metabolite features and an UPLC-TOF-MS human urine dataset that
reported 788 features. Both sets of data had been processed with XCMS similarly to the main
reproducibility study. Additionally, a synthetic dataset was made by modelling the distribution
of RT and m/z from the SUDS data of lab B. The RT distribution was modelled by a mixture of
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two Normal distributions with means µ1 = 110 & µ2 = 425 s and standard deviations σ1 = 60
& σ2 = 140 s and truncated at 0 minutes. The m/z distribution was modelled by a Normal
distribution, with µ = 200 Da and σ = 100 Da. Using these parameters, we simulated data sets
of up to 1,000,000 features. No false positives were found in either of the two biological data
sets. For the synthetic data set a maximum false positive rate of 0.07% was recorded. These tests
indicate that it is very unlikely that any of the detections reported in this study are false.
3.2.5 System Suitability Assessment
The SDS samples were used to assess system suitability, i.e. to determine whether each analytical
run was of acceptable quality to include in the study. To pass this assessment, we required a
minimum of 40% of the standards to be detected by the adduct finder as molecular ions (e.g.
[M + H]+ or [M − H]− ions). The peak shape of the detected ion was also required have a good
signal to noise ratio (minimum 5) as well as being approximately Gaussian, e.g. the peak could
not be flat topped due to detector saturation. The EICs of the molecular ion ([M + H]+ and [M −
H]−) of each standard compound detected in the SDS are shown in appendix figure 7.2. These
plots illustrate that for lab C negative mode, no molecular ions corresponding to the standard
compounds were observed. Additionally,figure 7.2b shows that few adducts of the standard
compounds were detected in lab C negative mode. Consequently, the lab C negative mode data
was removed from the reproducibility analysis. All other lab, mode and phase combinations
passed the system suitability assessment.
Phase A+ A- B+ B- C+
1 78 70 100 70 71
2 78 70 100 60 71
(a) All adducts
Phase A+ A- B+ B- C+
1 78 70 100 50 71
2 78 70 85 40 64
(b) Molecular ion only
Table 3.2: The percentage of detected compounds as either molecular ion or adduct. Each lab is
shown in both positive and negative mode.
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3.2.6 Reproducibility Measures
In this study [68] we report the reproducibility of all three recorded parameters: m/z, RT and
intensity. For mass, we report the mean mass measurement accuracy [115] (hereafter referred
to as mass accuracy). For retention time, we report retention time drift corresponding to the
retention times before correction by XCMS. For intensity, we report two measures. For within-
day repeatability, we report the coefficient of variation (CV) within each replicate group. For
between-day and between-lab reproducibility we report the R2 of a linear regression between the
mean intensities of ions detected in both conditions.
3.3 Results / Discussion
3.3.1 Detection of Spiked-In Standard Compounds
Raw extracted ion chromatograms (EICs) were inspected for each adduct of each standard com-
pound. Manual inspection of the peak shape and intensity confirmed the authenticity of each
detected peak. Figure 3.1 illustrates a typical set of EICs from the dilution series for hippuric
acid−d2, showing a well-defined peak in each case. The signal is seen to decrease in intensity
according to the two-fold dilution factors. As expected, we observed differences between the
three labs of both the mean and spread of retention times, with median retention times for labs
A, B and C of 190 s, 196 s and 193 s respectively. Lab C had the highest spread of reten-
tion times and poorest peak shapes which could be due to changes in the platform setup such
as change of column temperature1, fluctuating column pressures or flow rates and changes in
ionisation efficiency. The other main difference is that of peak intensity with Lab B having by
far the highest intensity, while labs A and C record similar intensities. Different peak intensi-
ties are to be expected when comparing MS results from different instruments and laboratories
1Under normal running conditions column age could also effect the retention times however, here all labs received
the same column therefore all columns were the same age.
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since source settings are usually optimised for each individual experiment (as in this case, see
appendix table 7.2 for details of source parameters). It should also be noted that Figure 3.1 shows
pre-aligned data and that the post-alignment peaks are all within 2 seconds drift.
Figure 3.1: Extracted ion Chromatography of
raw pre-aligned data from each labo-
ratory for Hippuric acid-d3 [M + H]+
The percentage of standard compounds de-
tected in each lab, phase and mode is given in
table 3.2. When considering all adduct forms,
the majority of the standard compounds were
detected in all data sets, with a minimum of
60% detected in lab B, negative mode. The
number of standards detected was similar be-
tween the two phases, indicating good within-
lab reproducibility. Detection rates were al-
ways lower in negative than positive mode,
though the only by 8% in lab A. Lab B,
however, showed a greatly increased detec-
tion rate in positive mode, detecting all stan-
dards, while labs A and C detected 78% and
71% respectively. Interestingly, labs A and
C showed little difference in detection rates
when the analysis was restricted to molecular
ions, while the detection rate in lab B dropped
by up to 20%, indicating a significantly in-
creased amount of adduct formation demon-
strated later in the chapter 3.3.4. To check that these differences were not simply a result of the
peak detection algorithm settings, we reprocessed the data using a lower signal-to-noise thresh-
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old with almost identical results (data not shown). Ionisation efficiency can be lower in negative
mode [116]. This effect could have resulted in the corresponding lower detection rate the stan-
dard compounds. Conversely, Nordstrom et al [117] found that metabolite coverage was similar
between ESI- and ESI+ modes in human blood serum extracts and it may be that the number of
standard compounds in our study is too small to draw a general conclusion in this area. For the
remainder of the analysis, molecular ion data is presented in the main figures, with equivalent
results including all adduct forms available in the appendix.
3.3.2 Within Run Repeatability of Intensity, Mass Accuracy and Retention
Time
For each standard compound, we calculated reproducibility measures for intensity, mass to
charge ratio and retention time for each set of analytical replicates across dilutions, phases, labs
and ionisation modes. Figure 3.2 reports this information for molecular ions ([M + H]+ and
[M − H]−); results for the full range of adducts are reported in appendix figure 7.1.
Overall intensity reproducibility was good, with median CVs of 12% and 17% for positive and
negative modes across all labs, phases and dilutions. The majority of CVs were low, with 70%
and 74% of features having CVs below 20% in positive and negative mode respectively. Across
labs, median CVs were 11%, 12% and 9% for labs A, B and C in positive mode and 17% and
15% for labs A and B in negative mode. The positive mode exhibited more high CV outliers,
particularly nicotinamide (162% and 62% CV in lab B phase 2, dilutions 1 & 2 respectively),
acetylcarnitine (58% and 27% CV in lab A, phase 1 & 2, dilution 1 respectively). These high
values are primarily due to the untargeted nature of global metabolite profiling, where more than
one unique peak can be assigned to a given feature by automated processing software, depending
on the m/z and RT tolerances set. Note that, although such errors could be corrected manually,
they are representative of error that would occur in any automated global profiling strategy, and
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have therefore not been corrected here. Tryptamine also shows an unusually high CV (71% CV
in lab A, phase 2, dilution 1). This was due to the fact that the corresponding peak was not
detected in all samples, an issue that affects the higher dilutions more severely, as a non-detected
peak will contrast more strongly with the high counts for detected analytes. Many other MS
based metabolic profiling studies have reported typical CVs of approximately 20%. Using an
HPLC-ESI-linear ion trap for urine, our study has shown very similar values to Gika et al [65]
for intra-day reproducibility. Our values show that 73% and 64% of peaks have a CV below 20%
in positive and negative modes respectively. A study on human cell extracts analysed by LC-MS
found inter-day CVs below 25% for 6 spiked-in compounds. Crews et al analysed serum and
cerebral spinal fluid (CSF) by HPLC-TOF-MS to show the overlap between the two biological
matrices [118]. They also demonstrated that the analytical variation in intensities was 15%.
However, the biological variation between the samples was high, > 50% and this is usually the
case irrespective of the analytical method [56,57]. Our work is consistent with Masson et al [119]
work where an optimised extraction protocol for liver recorded analytical CV of approximately
20% using UPLC-TOF-MS.
We observed a median mass accuracy of 4.4 ppm for positive mode but a substantially poorer
value of 11.8 ppm in negative mode. The mass accuracy was consistent both within laboratories
and across phases with median values of 3.5, 5.2 & 6.2 ppm for labs A, B and C in positive
mode and 11.0 & 9.9 ppm for labs A and B in negative mode. As with intensity, the lower mass
accuracy in negative mode is to be expected due to lower ionisation efficiency. In positive mode,
the compounds with the lowest mass accuracy were phenylalanine and acetylcarnitine. These
outliers could be attributed to saturation at high concentrations (phenylalanine) and the multiple
peak problem described in the above paragraph ( 3.3.2.3) for acetylcarnitine but also in more
detail in figure 1.2.
Drift in chromatographic retention times is a well-known complication in metabolic profiling
studies, complicating the process of matching peaks between samples. However, with UPLC the
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drift problem is much reduced, confirmed in our study. The median RT drift was remarkably
good at 0.73s in positive mode and 0.38 s in negative mode. 75% of RT drifts were below 2.12s
in positive mode and 0.67s in negative mode. These figures can be compared to typical RT peak
widths of 2-20s. As illustrated in Figure 3.1, RT drift varied across the labs, with median values
of 0.88, 1.61 and 3.55s for Labs A, B and C respectively in positive mode and 0.56 and 0.40 s
for Labs A and B in negative mode. It is important to bear in mind that the chromatographic
conditions were identical between modes and so ionisation mode cannot affect RT drift. Our
results are consistent with Lange et al found that RT drifts were below 5 seconds for the majority
of peaks in an untargeted UPLC analysis [44].
3.3.3 Linearity of Intensity with Dilution
Linearity in response of any analytical method is crucial. However, there have been no studies
investigating the linearity of response for multiple metabolites in complex biological mixtures
with TOF-MS. Table 3.3 reports the R2 for the regression of intensity against dilution for the
standard compounds in each lab, phase and mode (results including non-molecular ions are given
in appendix table 7.3 & 7.4 ). Overall, highly linear responses were obtained across the 16-
fold dilution gradient with median R2 values of 0.95 (compounds detected in n = 63 lab/phase
combinations) in positive mode (3.3a) and 0.93 (n = 15) in negative mode (3.3b). Across the
labs, median R2 values of 0.89 (n = 22), 0.95 (n = 22) and 0.98 (n = 19) were obtained for labs
A, B and C in positive mode and 0.93 (n = 12)& 0.89 (n = 5) for labs A and B in negative mode
respectively. This indicates minimal variation in linearity between the labs. Median R2 values
for phases 1 and 2 were 0.95 (n = 32)& 0.95 (n = 31) in positive mode, with 0.89 (n = 9) and
0.93 (n = 8) in negative mode, again indicating minimal variation between phases in linearity.
The poorest linearity was observed for tryptamine with an R2 of 0.41 for lab A in positive mode
phase 2, due to the signal falling below the limit of detection at lower dilutions. Hippurate in
negative mode lab B phase 2 also showed poor linearity (R2 = 0.49). This was due to a single
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Compound A Pos A2 Pos B Pos B2 Pos C Pos C2 Pos
Acetylcarnitine−d3 0.69 0.57 0.79 0.97 0.53 0.91
Adipic acid-d8 0.99 0.98 0.97 0.97 0.99 0.99
Dimethylglycine-d6 0.96 0.97
DL-leucine−d3 0.91 0.75 0.94 0.99 0.99 0.98
DL-methionine-13C 0.96 0.90 0.89 0.92 0.97 0.98
DL-phenylalanine-13C 0.68 0.74 1.00 1.00 1.00
Dopamine−d4 0.93 0.82 0.95 0.93 0.95 0.95
Glutaric acid−d4 0.93
Heptanedioic acid−d4 0.94 0.63 0.96
Hippuric acid−d2 0.89 0.85 0.96 0.97 0.98 0.99
L-DOPA-ring−d3 0.91 0.84 0.95 0.93 0.97 0.98
Nicotinamide−d4 0.96 0.94 0.87 0.91 0.95 0.97
Tryptamine−d4 0.89 0.41 0.95 0.98
(a) Positive mode
Compound A Neg A2 Neg B Neg B2 Neg
Adipic acid-d8 0.95 0.93
DL-leucine−d3 0.95 0.98
DL-phenylalanine-13C 0.80 0.93
Glutaric acid−d4 0.83 0.98 0.89
Heptanedioic acid−d4 0.95 0.96
Hippuric acid−d2 0.90 0.89 0.70 0.49
Succinic acid−d4 0.87 0.93 0.69
(b) Negative mode
Table 3.3: Dilution series R2 values for each lab, phase and compound. Blank entries are where
the compound was not detected in more than 50% of the samples for one dilution
series.
replicate in the most concentrated group having a much lower intensity than the majority of
the samples. If this sample is removed the R2 increases to 0.94. DL-Phenylalanine showed a
markedly lower linearity in lab A than the other two labs. This was due to higher variability of
intensity at dilutions 1 and 4 in lab A as seen in figure 3.1.
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3.3.4 Adduct and Dimer Formation
To facilitate a straightforward comparison between the phases and laboratories, the results re-
ported thus far have been confined to molecular ions. Nonetheless, many adducts and dimers of
the standard compounds were detected, a total of 35 and 20 distinct ions (including molecular
ions) in positive and negative modes respectively, illustrated in Figure 3.3 & 3.4.
In both modes, the molecular ion ([M + H]+ or [M − H]−) was the most commonly identified
adduct form. Clear differences between laboratories were seen in the amount and types of adducts
found. For labs B and C in positive mode, the sodium adduct, [M + Na]+ was the next most
commonly detected form; however this was not seen in lab A. Overall, lab B detected the most
adducts, with 12/14 standard compounds detected in more than one adduct form in positive mode
(4/7 in negative mode). These differences may be due to differing optimal MS source settings,
such a source voltage and source temperature. Only one compound, acetylcarnitine, showed a
propensity for consistent adduct formation in all labs (positive mode), while three others were
detected as adducts in two or more labs (phenylalanine and hippuric acid in negative mode and
L-DOPA in positive mode).
3.3.5 Between-Day Reproducibility
We estimated inter-day reproducibility using a subset of identical samples run in phase 2, at
least one week after phase 1. Spectrometer intensity response can vary over time, especially
between before and after cleaning the instrument. Therefore in this instance the comparison of
absolute intensity measurements does not demonstrate the normal reproducibility. Instead we
assessed reproducibility by examining quality of the linear relationship between intensities in
the two runs, as shown in Figure 3.5. R2 values from the regression of phase 2 against phase 1
intensities were above 0.84 in all cases, with a mean of 0.93, indicating excellent reproducibility.
Two comparisons showed lower R2 values: lab A negative mode, and lab B positive mode. In
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neither case could the lower reproducibility be attributed to individual (or groups of) standard
compounds, adduct types, or dilutions. To our knowledge, no other studies have investigated
inter-day reproducibility of LC-MS based metabolic profiles of urine.
3.3.6 Between-Lab Reproducibility
The lab-to-lab studies measure one of the most important aspect of analytical reproducibility.
As for the within-lab measurement, it is not meaningful to compare absolute responses and thus
we look for a linear relationship between intensities in pairs of labs. Further, given that each lab
optimised its own spectrometer settings, ionisation efficiency would be expected to be compound
specific and thus each compound was modelled separately. Figure 3.6 shows a separate regres-
sion line for each standard compound adduct which was detected in all dilutions for each lab pair
and illustrates that the response is highly linear between each pair of labs in both positive and
negative modes. In positive mode 24 compound-lab pair matches were made with a median R2 of
0.96, and 79% of values above 0.90 indicating excellent reproducibility. In negative mode, only
four compounds could be found in both labs, yet the median R2 was 0.98, and three of the four
had values of 0.96 or higher. R2 values for each standard can be found in appendix table 7.5 &
7.6 . Some compounds showed lower R2 values. For example, acetylcarnitine gave an anomalous
response in lab B at high intensities, but a highly linear relationship was seen for this compound
when comparing labs A and C (R2 = 0.96). L-DOPA appeared to saturate the detector in lab
A, but again this effect was not seen in labs B and C (R2 = 1.00). To our knowledge there have
been no studies investigating inter-lab reproducibility of LC-MS for metabolic profiling of urine.
For NMR, Keun et al [56] have shown excellent inter-laboratory reproducibility with R2 values
above 0.93 for three metabolites in rat urine measured at 600 Mhz.
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Figure 3.5: Between-day reproducibility of intensity for each laboratory and mode. Each data
point corresponds to a single standard compound adduct averaged across all repli-
cates at a given dilution.
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3.4 Conclusion
The study presented here is the first one to examine reproducibility of UPLC-MS for urinary
metabolic profiling comprehensively across three levels: within-day, between-day and between
labs. By spiking stable isotope labeled standard compounds into a complex biological matrix,
and using standard global profiling software tools, we have been able to estimate reproducibil-
ity of untargeted metabolic profiling using identified compounds, thus increasing confidence in
our estimates. We have shown that all three aspects of the experiment are reproducible, with
median CVs for intensity of less than 18%, median mass accuracy below 12 ppm and median
retention time drift less than 0.73 s. Within each run, the intensity response is highly linear for
most compounds, with a median R2 of 0.95 in positive and 0.93 in negative modes, despite the
complex background of diverse urinary constituents. Between-day reproducibility was excellent
(even with runs separated by at least a week in which instruments were used for other projects),
with a mean phase 1 to phase 2 correlation R2 of 0.93 across the labs and modes. All compounds
were found to form adducts and/or dimers to an extent which varied widely between the labs.
Finally, we have shown that intensity responses are also highly reproducible both within a lab
and between labs with median inter-lab R2 of 0.96 in positive mode and 0.98 in negative mode
respectively. This implies that the intensity ratio for a given metabolite across different samples
(for example the fold change between two biological conditions) will be highly reproducible.
While we have not shown in detail we suggest the need for strict system suitability and qual-
ity control criteria. Overall, we can conclude that UPLC-MS is a highly valuable technique for
global metabolic profiling, yielding measurements of thousands of features which are highly re-
producible both within, and between different labs.
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4 Characterising the Static Correlation
Structure in LC-MS Data for Structural
Identification and Removal of Analytical
Artifacts
4.1 Introduction
Mass spectrometry is a commonly used method for exploring biological samples and has become
widely used in metabolomics. Samples are analysed according to their mass to charge values
(m/z), which is helpful in metabolomics with the limited mass range. Used in conjunction with
mass spectrometry to separate chemicals according to chemistry is liquid chromatography (LC).
A final 3 dimensional dataset is produced for each experiment with m/z, retention time (rt) and
intensities. As discussed in section 1.3.1 many software platforms have been designed to analyze
this data. Among these are openMS [120] a popular proteomic software platform, MZmine2 [47]
which places an emphasis on graphical output and display and XCMS. XCMS [49] is a popular
metabolomics platform written in R and is highly modular. Commonly, these platforms find
1000s of m/z-rt pairs or features across a dataset. However, these features are not unique to
a particular molecule and any one molecule can have multiple ions. These ions are adducts,
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isotoplogues and fragments. The intensity of the variables from MS are highly correlated. These
correlations come about by different processes taking place. These processes can be :
• Structural process Structurally related ions such as isotopes and adducts.
• Biological processes chemicals are biologically related in a pathway or are being con-
trolled by the same biological event.
• Analytical process A non-biological or structural chemical change in the way that each
metabolite is related to each other. This could happen due to column changes with cer-
tain chemistries as the alky chains gain more or less affinity for the chemistries. Another
way would be due to poor extraction efficiency, where some metabolites were extracted
at a lower or higher efficiency between samples. This change can be a non-linear change
however, here we have looked at a linear change.
There have been many publication on the identification of structural pairs within LC-MS
datasets. They have shown that these structural pairs can be identified a number of ways in-
cluding intensity ratios, retention time (RT) windows and correlation [106, 121, 122]. However,
correlation is a common area of research for identifying structural links especially in automation
with programs [51, 123, 124]. There are two main ways in which the data can be correlated find
adducts, fragments and isotopes in these large metabolomics datasets. The difference between
them is the data that they use in the correlation. The two main ways are:
• Within file correlation (WFC) - This is where the peak height, intensity data from a cen-
troided peak (not peak integration) is used for correlation. The correlation can only hap-
pen between peaks that are within a selected RT window. This is the method that Kuhl et
al [51] uses and utilises a density window to allow for a non statically defined RT window.
To define the window the peak with the largest maximum peak intensity is chosen. Then
the median RT of that integrated peak is used to make the RT window. All peaks that
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are within the window are chosen for pairwise correlation. This is outlined in figure 4.1.
Using a similar method Scheltema et al reduces the LC-MS datasets and eases identifica-
tion [125]. This method was shown to reduce the dataset by 60% on test data. A normal
range of structural pairs in general is between 50-75% of the data. Brown et al. [80, 122]
uses within file Pearson correlation for identification of the frequency of adducts and iso-
topes in a dataset. No RT window was set allowing a wide analysis of the accuracy of the
required RT window. The most frequent structural identification was 13C. A graphical user
interface for xcms [49], IDEOM [124] uses the same method of WFC for structural pair
identification.
• Across file correlation (AFC) - AFC is an easier technique to implement, where the inte-
grated intensity of the peak from each file for any pair of features are correlated. This is
the method that Alonso et al [123] uses in the publication. The RT window is defined in
a stricter sense where a simple RT window is implemented around the median RT of the
first selected peak in the pair by m/z.
After the correlation has shown that the peaks are related, a lookup table of mass differences, can
be used to try and identify what the adducts are. Both of these methods are able to successfully
identify related structural pairs in the dataset which is normally around 50%-75% of the peaks.
In the Kuhl publication a score is made where both WFC and AFC are used to allow for a high
confidence in structural pairs. As long as the peak is able to be separated and there are no other
peaks that are co-eluting the WFC method is more robust as inter sample noise can lower the
correlation coefficient of the AFC method.
There are many other correlations that are not structural. These correlations do not have over-
lapping RT windows and are defined as biological correlations with the underlying processes
causing them outlined above. Biological correlations can only be found using the AFC method
with no needed RT window. The correlations also need to be in samples that represent biological
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Figure 4.1: The figure demonstrates the intensity data that is correlated in the WFC method. It
can be seen how each point on the peak is correlated between the other peaks. Only
peaks within the RT window will be correlated.
change and not QC or QC like samples.
Before the biological processes behind the biological correlations can be explained, good data
must first be extracted. The pooled biological quality control samples, deemed QC samples [126]
as explained in section 1.4, can help to identify features with high analytical variation. These
QC samples are used to measure the analytical variation and show the variation in a repeated
measurement. Poorly performing features can then be excluded using coefficient of variation
(CV) above a certain value, commonly 30%. Research teams can then use the resulting data to
form networks with the correlations. These correlations networks are increasing in popularity
within the metabolomics field [89] and the wider omic field [127]. Many network based anal-
yses have helped explain the biological experimental hypothesis [91, 128, 129] and many newer
network based algorithms have been published and used in to demonstrate the usefulness of net-
works [130, 131].
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Finally, analytical correlations can be induced for example, by changes in the column chemistry
for different functional groups over the run, delayed quenching between samples collection or
changing extraction efficiencies. To our knowledge these correlation have been largely ignored,
with the exception of Karakach et al [132] that showed that these correlations or covariances
affected PCA analysis for NMR data. These analytical correlations can cause many problems
when trying to understand the data. First, the analytical correlation could be mistaken as a bi-
ological correlation, leading to erroneous results. PCA is a very popular multivariate analysis
technique used in metabolomics. As previously described the technique uses a covariance ma-
trix. While not a statistical assumption there is generally an assumption with PCA analysis that
the covariance of the features has been caused from biological variation. Again, the analytical
correlations could cause erroneous results.
Here we demonstrate that correlation can significantly improve the identification of structurally
related signals over simple small retention time windows. We present global correlation distri-
butions for the biological & QC samples, showing that these distributions are relatively stable
between datasets and LC methods. While it is very difficult to separate the structural and ana-
lytical correlations from the biological one, as each one is a function of the other, we present a
method for removing correlations that come from the analytical process and show that the result-
ing network is statistically different than a network that has had nodes randomly deleted. This
final network is a highly improved correlation network with greater confidence that each edge
has a non-analytical process behind it 1. It is believed that this method will have a wide range of
uses where ever correlations or covariances are used in analytical data.
1This is most likely to be a biological process as all other known processes have been accounted for.
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4.2 Methods
4.2.1 Sample Preparation & Data Acquisition
Two different datasets were obtained. The first was a urine dataset collected from a in-vitro
fertilisation (IVF) pregnancy study, dataset A. The study had two biologically relevant groups:
patients that remained pregnant and those that did not. The second is a tissue dataset from artery
plaques in humans, dataset B. Below is a brief description of the methods used herein, the full
details of the analytical methods will be published at a later date. The objective of the chapter is
show the use of the data in the development of the informatics methods.
Dataset A
Urine samples were collected from 14 different patients who were on IVF treatment. The sam-
ples were collected each day over the course of the first month of IVF treatment. The sample
collection was a spot collection. The urine samples were treated with sodium azide (at 0.1 g per
100 mL of urine) and filtered at 0.2 µm to remove particulates and cells. Dataset A data was col-
lected on a LCT Premier TOF mass spectrometer (Waters MicroMass, U.K.) with electrospray
ionisation (ESI) source. Using a C18 Acquity (2.1 mm x100 mm, 1.7 µm) columns (Waters) the
chromatography gradient was over 14 min, with mobile phases A (water, 0.1% formic acid) and
B (acetonitrile,0.1% formic acid). The gradient is summarised as follows: 0 min 100% A, 0%
B; 4min 80%A, 20%B; 9min 0%A,100%B; 11min 0%A, 100% B; 12min 100%A, 0%B; 14min
100%A, 0%B.The flow rate was 0.5 mL/min, and an injection volume of 5µL was used. The
mass spectrometer was set to scan from 85 to 1000 in mass to charge ratio (m/z), calibrated with
sodium formate. Sample temperature was maintained at 4 ◦C and column temperature at 40 ◦C.
Quality control (QC) samples was used for the UPLC-MS analysis. Briefly, a pooled sample of
the reconstituted extracts was prepared. This sample was re-injected 10 times before initiating
the run to condition the column. Then the sample was re-injected once at the beginning, every
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10 injections of samples, and at the end of the run2.
Dataset B
Parts of plaque tissue, and intact tissue adjacent to plaque, were dissected and forwarded to
metabolite extraction. Pre-chilled methanol:water solution (1:1) (methanol HPLC gradient grade,
Fisher; water LC-MS grade, Fluka), was added to the tissue samples. Samples were centrifuged
(Eppendorf) at 13,000 rcf for 20 min, at 40 ◦C, followed by aliquoting at 250µL of supernatant
into Eppendorf tubes. Samples were then spun to concentrate the samples. Reconstitution of
the samples was done in 200µL of solvent mixture of H2O/acetonitrile (5:95) (LC-MS grade,
Fisher Scientific, USA and centrifugation for 20min at 13000 rcf and 4 ◦C. An Acquity UPLC
BEH HILIC 2.1x100mm, 1.8µm, column (Waters, Milford, USA) was used. Injection volume
of 10µL was used for positive and negative ionisation modes. Mobile phase A consisted of
acetonitrile/water (95:5) and mobile phase B acetonitrile / water (50:50). The chromatographic
gradient was 23 min summarised as follows: 0 min 99%A, 1%B; 9min 1%A, 99%B; 23 min
1%A, 99%B. Detection of eluting UPLC fractions was achieved using a Premier Q-TOF (Waters
Corp, USA). Data was collected with a mass range of 50-1500 m/z. A set of QC samples were
made up in a similar fashion as in the method for dataset A3.
4.2.2 Peak Detection and Alignment
The data was converted into netCDF using Waters MicroMass databridgeTMsoftware. The files
were then sorted into their different classes, with QC samples having their own class. For dataset
A this was P (pregnant), NP (non-pregnant) and the QC samples. Peak detection and alignment
was performed by XCMS (version 1.30.1). The ’centWave’ peak detection algorithm was used
for high mass accuracy, using peak widths of 3-20 sec, lock mass correction was used [108].
2We would like to thank Elizabeth Want and Peter Dixon for data and sample collection
3Thanks is given to Panagiotis Vorkas who collected and developed the analytical methods for the data
86
Grouping was performed with the ’nearest’ algorithm, and alignment used the following pa-
rameters, missing=2, extra=3. The ’nearest’ grouping algorithm was used due to many closely
eluting peaks between samples and a better performance was observed with this algorithm over
the default density algorithm. Both datasets were normalised with a median fold change normal-
isation [74]. A minFrac of 50% was imposed on the data, which removes any peaks that are not
detected in < 50% of samples for any one class, including the QC class.
A CV of cutoff of 27% was used for dataset A and a 26% CV filter was used for dataset B.
This corresponded to the median CV in both datasets. The median CV is a useful measure as
previously stated, and this allows for removal of 50% of the data. These CV’s were calculated
from the across the QC samples, any feature that had a CV above this value was subsequently
removed. The resulting dataset A had 2321 features across 9 samples. The number of samples
was reduced due to the collection of data being outside of the specified 1st month of pregnancy.
Dataset B had 1044 features across 146 samples. Again a CV filter was used on the QC samples
to return only reproducible data.
4.2.3 Manual Detection of Adducts & Isotopes
To be able to assess the ability of correlation to find adducts and isotopes a list of known com-
pounds in urine, as shown in table 7.7 and previously identified compounds in dataset B shown
in table 7.8 were used to search the data matrix. An in-house R script was made to automatically
find adducts and isotopes from named compounds within the data matrix by using retention time
windows and explained m/z differences. This script was described in section 3.2.3. Briefly, the
script takes a list of m/zs from a targeted list and calculates all possible adducts, isotopes and
fragments using a list of possible adduct forms. The output is a list of any feature that matches
the adduct, isotopes or fragments that is within the RT and m/z range specified. For both datasets
a range of 25ppm was used and a range of 10s was used for the RT window. A list of the calcu-
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lated adducts can be seen in table 7.1
The results from the script were then verified by manual inspection. Conformation of isotopo-
logues and adducts pairs were done by manual inspection of linked EICs. Figure 4.2 shows an
example plot. These plots were generated for possible structural pair. These complex plots were
directly used for the confirmation of each pair and contained the following:
• Extracted Ion Chromatographs of each feature in the pair - The EIC’s are very informative
as they show if the peak is real. The criteria is being roughly Gaussian and intensity above
local noise. While all peaks should be above a signal to noise of 5, some peaks were
close to or difficult to discriminate from the local noise by eye. In these case the peak was
excluded
• A feature definition plot - These indicate where each peak from each sample was detected
in terms of m/z and RT. These are very useful for defining if there are extra peaks not
belonging to the feature are present. For example if a sample had two peaks within the
feature box.
• A Mass Spectrum - This plot helped to understand where the peak was coming from and if
it was actually an isotopologue or if it was the molecular ion. Although there is no precise
method for identification of the isotopologues, the overall pattern needs to be an isotopic
pattern that is normally seen with metabolite. The expected pattern is a majority of 12C
and then a smaller peak with 1 13C etc. It is also helpful to check that the isotope is +1 m/z,
unless the identified feature is believed to be multiply charged.
• Integrated Intensity plots - these plots show the integrated intensity across all samples.
This can indicate if there was a falling intensity across the run. If there is a falling intensity
normalisation can normally help.
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Two sets of the example figures have been shown; one for an accepted structural pair 4.2a and
one for a rejected structural pair 4.3. After all pairs had been verified a list of accepted structural
pairs was made. This set was a set of true structural pairs. A set of false pairs was any feature
that did not have an overlapping RT and therefore could not be structural pairs. A 5 second RT
window was used for the exclusion of structural pairs. Using ρ as a threshold to declare pairs
as structural (positive) or non-structural (negatives). A Receiver Operator Characteristic curve
(ROC) was calculated by varying the ρ threshold. Plotting of the (ROC) was done using the pCor
package. The following definitions were used for the confusion matrix:
• True Positives (TP) - These were confirmed structural pairs via the structural pair plots that
had a ρ > the chosen threshold.
• False Positives (FP) - These were confirmed non-structural pairs that had a higher ρ than
the chosen threshold.
• True Negatives (TN) - Confirmed structural pairs that had a ρ < the chosen threshold.
• False Negatives (FN) - Confirmed non-structural pairs that had a ρ < the chosen threshold
Using these pairs a calculation of sensitivity and specificity was done using the Pearson corre-
lation of all feature pairs to produce the ROC curve.
4.2.4 Statistical Correlation Dependency Network
For both datasets the samples were combined into two categories, biological samples and QC
samples. The QC samples should have no detectable biological process to influence the correla-
tion and consequently need to be in a separate category.
The intensities of the features in each category were then correlated using Pearson correlation.
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The resulting correlation matrix was then used for network construction of the ’biological net-
work’ using the biological samples and the QC sample for the ’QC network’. Each network was
made using the igraph [133] package, any edge having a ρ ≥ +0.75 or ρ ≤ −0.75. A value
of ±0.75 was chosen as weak spurious correlations would be removed and only stronger cor-
relations would remain. However, as this is a proof of principal the final chosen value is not
essential. The networks were made for both datasets, independently. In the networks the nodes
are the features and the edges or connections are the correlations between the feature pairs.
Filtered Network
An improved ’filtered network’ was made from the biological and QC networks. The QC net-
work, which has analytical and structural correlations can be used to remove edges which are
statistically similar in their ρ to the biological sample network. These edges should be analytical
edges however, depending upon the dataset the edges removed could also be structural.
To do this the QC network was bootstrapped, a method of resampling with replacement. The
bootstrapping was performed by bootstrapping the QC samples 5000 times and remaking the
correlation network for each bootstrap. The bootstrapping gave a distribution of ρ for each pair
of features. From this distribution a mean, rhoqcBoot and standard deviation, σqcBoot was used in
the Z transformation, equation 4.1. The ρbio was used to transform in the Z domain. The Z trans-
formation allows for a higher resolution p-value. The p-value is the probability the correlation is,
or more extreme than ρbio could be observed in the QC network. Therefore, any edge with a low
Z f iltered value i.e. high p-value was removed since correlation may have resulted from analytical
procedure alone. The chosen threshold p-value was > 0.05 post Bonferroni correction. This
made the new network, the ’filtered network’.
ρbio − ρqcBoot
σqcBoot
= Z f iltered (4.1)
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Testing the Filtered Network
The new ’filtered network’ needs to be tested that it was statistically different to a network that
can be generated by randomly deleting edges from the biological network. This was performed
by randomly deleting edges from the biological network. This process was repeated 1000 times
deleting the 578 edges each time. This number corresponded to the difference between the bi-
ological and filtered network edge number. For each iteration, the shortest average path length,
betweenness centrality and degree statistic were recorded. Both the degree and betweenness
centrality statistic were also recorded as a rank statistic. This was done by calculating the rank
difference between the original biological network and the iterated random deletion network.
Another way to test the new filtered network is to calculated how different it is from the bio-
logical network. While simple statistics on the biological network give an answer it is unknown
what error is associated with these measurements. Consequently, a method is needed to generate
a network that is no different from the biological network except by permutation of samples.
This network is a null network. This null network describes the error boundaries of the origi-
nal biological network. It is important to know how different the null network is to the filtered
network. If the filtered network is within the boundaries of the null network then it could be no
different than a permutation of the biological network. A null model network was defined using
equation 4.2. The null model is made in a similar fashion as the filtered network.
ρbio − ρbioBoot
σbioBoot
= Znull (4.2)
Using equation 4.2 the biological samples are bootstrapped and for each bootstrap a new cor-
relation matrix is made. The distribution of each pair of features is then used to find the mean
ρ, ρbioBoot and the standard deviation σbioBoot. These are then used in a transformation to the Z
domain by subtracting the ρbio for that particular pair of features. Again, these Z values were
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converted to p-values where, after Bonferroni correction any p-value that was ≤ 0.05 had the
corresponding feature pair/edge removed. Using the same cutoff ≤ −0.75 & ≥ +0.75 a network
was made in a similar fashion as before. 5000 unique bootstraps were performed calculating a
new network each time. The rank betweenness was also performed on the new null network,
again ranking against the biological sample network.
In total there are now 5 different networks they are as follows:
• Biological Sample Network - This is the original network from the correlation matrix of
the biological sample category
• QC Sample Network - This is the network from the correlation matrix of the QC samples
category.
• Filtered Network - This is the network that uses the bootstrapped QC samples to remove
analytical correlations. This network was made using equation 4.1
• Random Edge Delete Network - This is the network that was derived from the original
Biological Sample Network but has had edges deleted at random.
• Null network - This is the null model network to examine the variability in the biological
network. This network was made using equation 4.2
4.2.5 Network Visualisation
Using VANTED [134] the network was first visualised using the grid layout. In this mode sin-
glelet nodes were deleted. The layout was then reselected to circular and finally to a force
directed layout. This allowed the same nodes to be in similar locations between the original net-
work and the filtered network.
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4.3 Results and Discussion
Both datasets showed that correlation is a useful technique to distinguish structurally related
compounds within a defined retention time (RT) window. Using a combination of automatic
analysis using a previously published script [68] and manual inspection to identify adducts, iso-
topes and fragments, 65 structurally related features with 72 pairs, were detected for dataset A.
In the B dataset, 32 structurally related ions were detected with 36 pairs. After manual confor-
mation, based on peak shape, peaks that had overlapping RT windows, mass spectra plots and
feature definition plots, as demonstrated in figure 4.2, 25 adduct and 8 isotope pairs were iden-
tified for the dataset A. Dataset B resulted in 11 adduct and 7 isotope pairs. Dimers were also
detected during this search with 3 monomer-dimer pairs in dataset A and only 1 pair in dataset B.
4.3.1 Adducts & Isotopes ROC
Figure 4.4 shows performance statistics for detecting structurally related pairs using a correlation
threshold and retention time windows. As previously discussed in section 4.2.3, a confusion
matrix was setup for the adducts and isotopes. The positives examples were adduct pairs that
were deemed to have to correct mass difference and were within the retention time window that
was specified. These positives were manually confirmed via confirmation plots. Negatives were
defined as any non-structural pair outside of the RT window. The graphs show that the false
positive (FP) rate is very low at high cutoffs or correlation coefficients (1.5% at ρ = 0.75 Dataset
A, adducts). The isotopes have a similar false positive value for the same cutoff as the adducts,
6% at ρ = 0.75. Dataset B had higher FP rates than dataset A, at 5.5% (ρ = 0.75) for adducts
and 6.7% (ρ = 0.75) for isotopes. However, this value is affected by the low resolution of the
curve, due to a lower number of confirmed structural pairs. Yet the positive predictive value
(PPV) shows that dataset B is more accurate in predicting both isotopes and adducts. PPV shows
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the proportion of pairs predicted to be structural that are correctly identified at the corresponding
cutoff.
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Figure 4.4: Performance statistic for the ability of a single correla-
tion threshold to identify structurally related ions. A -
adducts & B -isotopes dataset A. C adducts & D - iso-
topes dataset B.
The PPV is a maximum
at the following cutoffs
25% PPV at ρ = 0.72 in
dataset A and 50% at ρ =
0.95 for dataset B with the
adducts and 25% at ρ =
0.82 in dataset A and 80%
at 0.99 ρ in dataset B for
the isotopes. The PPV
value shows that a sin-
gle threshold is more pre-
dictive for isotopologues
pairs than adduct pairs,
which is to be expected
given their higher correla-
tion coefficients. The PPV
is also heavily influenced
by negatives. This is particularly important when trying to compare between datasets. The PPV
does not have the same prevalence between datasets, that is to say the number of confirmed struc-
tural & non structural pairs is different between the different datasets. This therefore, arbitrarily
increases the PPV value for dataset B.
The ROC curves from figure 4.5 demonstrate that the using Pearson correlation of intensity
values with retention time windows is an effective way to identify structurally related pairs. The
area under the curves (AUC) are above 89.8%. The isotopes show the same trend as the false
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Figure 4.5: Receiver operator characteristic (ROC) curves for the performance of a simple cor-
relation cut off in identifying structurally related pairs of features. These pairs were
manually identified adducts and isotopes in both datasets. Graph A is the ROC curve
for adducts of dataset A. graph B is the isotopes for dataset A, graph C are adducts for
dataset B and graph D is the isotopes for dataset B. The isotopes ROC curves have a
much higher area under the curve (AUC) than the adducts in both datasets. The error
bars shown in blue are a 95% confidence interval calculated via 2000 bootstraps.
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positive rates (97.5% (C.I. 94.7 − 100.0%) dataset A & 98.3% (C.I. 96.0 − 100.0%) dataset B)
having a higher AUC than the adducts (93.0% (C.I. 89.2−96.8%) dataset A & 89.6% (C.I. 84.4−
94.7%) dataset B). This increase in variation of correlation and reduced correlation coefficient
may be due to the small changes in source conditions across samples that effect the ionisation
of the adducts. These results are inline with what has been found using the scoring system
published in Kuhl et al where a 84% AUC was found. However, Kuhl’s [51,135] uses a complex
scoring system that uses a binary score for the presence of isotope peaks, a WFC and a AFC.
This means that the 84%AUC is not directly comparable to the AUC described here. Further
more the method by which the false positives are defined is also different. The paper defines
the false positives by artificially moving randomly selected peaks to co-elute with the known
molecular ion. This method is needed due to the use of the WFC being included in the score.
With the complex scoring system and confirmation between the two structural pair correlation
methods, WFC and AFC it would be expected that the AUC would be better. The number of FPs
is probably higher than it should be due to more WFC causing a higher ρ. This would decrease
the specificity and consequently the AUC.
4.3.2 Correlation in Relationship to Other Parameters
Using the known compounds in dataset A the adducts and isotopes were checked to see if there
was any relationship with other chemical parameters. The tested parameters were: logP and Po-
larity. The frequency distributions plots of Pearson correlation, against these parameters showed
no identifiable relationship with either of these parameters. It could be due to the low amount of
identified compounds and a wide numerical range for both logP and Polarity both of which were
referenced values. It would be expected that with specialised source setting that a relationship
could be formed between these parameters and the number of adducts however, given that the
source settings are generalised for all expected ions this is much less likely.
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4.3.3 Non Structurally Related Correlation Pairs
Many of the high correlations are between non-structurally related pairs. Pairs that lie outside of
the retention time windows and still have a high correlation are most likely not structural pairs.
These pairs are most likely biological correlations or analytical correlations as described earlier.
Seen in equation 4.3 there are substantially more non-structural pairs than structural.
No. o f non − structural pairs = 2321
2
2
− (2321 ∗ 3) = 2.7x106 (4.3)
If it is assumed that each of the 2321 features (dataset A) will have 3 structural pairs then the
non structural pairs will be 2.7 × 106 and 6963 structural pairs. A distribution of correlations
for both sets of sample categories, biological samples and QC samples can be seen in figure 4.6.
This distribution was again made by a pairwise correlation of intensity of the features. Pairs
that were within 5 seconds of each other were removed. This was done to reduce or remove the
structural correlations. Consequently, the distribution seen in 4.6 should only be a distribution
of biological and analytical correlations.
As previously mentioned the biological samples have biological information. Whereas, the
QC samples are the pooled biological samples, these samples give information about the re-
peatability of the method and instrumentation. Consequently, the distributions for the two sam-
ple sets should be different. As expected the mean (µ) of the distributions are close to 0 for both
datasets (biological 0.01 dataset A & 0.01 dataset B QC samples 0.03 dataset A & 0.15 dataset
B). However, the standard deviations (σ) are much larger for the QC samples in dataset B (0.19
Biological, 0.38 QC samples). This is suggestive that the QC distribution is closer to a random
distribution and therefore many of the correlations are spurious/random correlation. Dataset A
has little difference between the standard deviation of the classes (0.20 Biological & 0.28 QC
samples). The biological samples distribution is a tighter distribution due to the biological vari-
ation which, on a mean level comparing CVs, is know to be quite large [62, 118]. The larger
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Figure 4.6: Non-structural correlation distributions from the Biological and QC samples. The di-
agonal of the correlation matrix was removed along with a 5second window around
the diagonal. This removal had the effect of removing structural pair correlations.
The distributions for the biological, analytical and structural distributions in the bi-
ological samples and the analytical and structural distributions for dataset A on top
and dataset B below.
variation means that correlations are not due to random correlations as seen in the QC samples
that should have a small variation. The larger variation of the biological samples cancels out the
smaller variation of the analytical process known to be much smaller [68, 112]. Any real corre-
lation from the QC samples cannot be biological correlation as the QC samples are a uniform
mixture of the various biological samples thereby removing any biological effect. The strong
correlation in figure 4.6 are not structural as they have been removed. These real correlations
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must therefore be analytical correlation.
4.3.4 Effects of Analytical Correlations on Inferred Statistical Dependency
Networks
Commonly, inference networks are made to help in the analysis and understanding of omics
data [89, 136]. These networks could be highly influenced by correlation induced purely by
analytical process and thus not deriving from true biological relationships. Additionally the an-
alytical process could reduce or eliminate biological correlations in some cases. We therefore
aimed to investigate this by removing or reducing correlations that are from an analytical corre-
lation origin. For this set of analysis only dataset A was used.
Using the integrated intensities of the features in the biological samples, pairwise correlation
was used to make a correlation matrix. From this correlation matrix any correlation over ρ ≥ 0.75
& ρ ≤ −0.75 was used to make a feature correlation network. The structural correlations were
expected to be revealed as tightly grouped and highly connected sub-networks where as the ana-
lytical and biological correlations structures were harder to define and identify. Ideally, the edges
would be just biological correlations. It is not straightforward to separate the distributions into
their component parts. Each distribution is a function of the other. Structural correlations are
fairly easy to classify and most analytical correlations should be weak correlations. This can be
tested and any correlation that is being driven by the analytical correlation can be removed, using
the QC samples.
The QC samples were bootstrapped to form a ρ distribution for each pair of features. Using
this distribution a z test could be performed using the same pair in the biological samples. The
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z values could then be transferred to p-values. If the p-value was not significant (> 0.05), that
is to say that the ρ for the biological samples pair was within the correlation coefficient distri-
bution of the QC samples, the edge was deleted in the filtered network. This filtered network
is visually similar to the unfiltered network, figure 4.7. Both graphs were assembled in identi-
cal ways, thereby allowing a visual comparison between the locations of the different sub-graphs.
Filtered NetworkBiological Sample
Network
Figure 4.7: A force directed layout of both the original biological sample network and the filtered
network. Many visual similarities can be seen, while some sub-graphs have been
reduced in the number of edges and nodes. The circled sub-networks correspond to
the same group of nodes in both networks. A visual difference can be seen between
the circled sub-networks between the original biological sample network and the
filtered network.
There are many highly connected sub-graphs in both networks however, the filtered network
(7973 edges) has fewer connections than the biological sample network (8551 edges). This is
also shown by the drop in the average degree between the two networks dropping from 7.37 in
the biological sample network to 6.87 in the filtered network. Due to drop in the number of edges
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there is also a small rise in the number of singlet nodes in the filtered network (921 nodes in the
biological sample network to 949 nodes in the filtered network).
To assess whether the filtered network was statistically different to deleting random edges from
the biological sample network a series of randomly deleted edge networks were created. In each
iteration, a randomly selected list of edges (578 edges each time), from the biological sample
network were deleted. Performed many times (1000), network statistics could be used to iden-
tify if the filtered network was different to the mean random edge deletion network. Figure 4.8
shows the distribution of average path length from the deleted network. The average path length
for the original network is 1.564 shown as the red line. The average path length for the filtered
network is less, at 1.552 the blue line in figure 4.8. It can be seen from the graph that the filtered
networks, average path length is different from the median 1.60 (σ = 0.02) of the random deletes
average path length. The edges that are targeted in the filtered network are the analytical and
the structural edges. The structural links are normally highly connected subgraphs and few ana-
lytical connects should be connecting between subgroups. This means that the overall network
structure should not change too much. A good example of this has been highlighted in blue in
figure 4.7. The decrease in the average path length between the original biological network and
the filtered network is due to the unconnected nature of the network. If there are few connections
between two subnetworks, seen highlighted in red of figure 4.7 (Biological network), and the
edges which connect the two subnetworks are broken to form smaller networks then the average
path length can decrease. There is a second smaller distribution in figure 4.8 which lies close
to the both the filtered and biological sample network. This is not unexpected as the method
randomly deletes edges and therefore could come very close to a network that is very similar to
the filtered network. However, these similar randomly deleted edge networks do not happen the
majority of the time. The degree distribution was also evaluated for the random edge deletion
networks. This did not show any significant difference to the filtered network.
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Betweenness is a commonly used network statistic and is a measure of how many paths be-
tween pairs of nodes, go through a given node. Figure 4.8 For each network the betweenness
values were ranked. Then the overlap of the top n ranked nodes were calculated for n = 1 to
2321 (all of the nodes) e.g. if half of the top nodes were the same for the networks, then the
overlap is 50%. The green line is the fractional overlap of the biological sample network ranked
against itself. Therefore, it is always at 100%. The black line is the fractional overlap of the rank
betweenness of the filtered network. It can be seen that the first 10 ranks there is an 80% rank
overlap to the biological sample network. The blue line is the random edge deletion network.
For the first 10 ranks there is a 89% overlap. Finally, the red line is the fractional overlap of rank
betweenness for the null network. The null network was made in a similar fashion as the filtered
network. However, where the filtered network used the QC samples category for bootstrapping
the null model uses the biological samples for the bootstrapping. This network makes sure that
the filtered network is not just a rearrangement of the biological sample network. This means
that if the filtered network is very close to the null network, then the filtered network is just re-
moving spurious correlations. The null network has a maximum overlap of 60% to the filtered
network for the first 10 ranks. The null network rank betweenness is very different than the fil-
tered network and stays outside of the 95% error bars for more than the first 600 ranks. The rank
betweenness shows that the filtered network is significantly different than the biological sample
network, the null network and the random edge deletion networks. When the edges are deleted
in the random edge deletion network the betweenness stays close to filtered network. However,
they are different and the random edge deletion network is closer to the biological sample net-
work than the filtered network for the first 200 ranks. This shows that the filtered network does
not resemble random edge deletion. Rather the filtered network has targeted edges to delete.This
changes both the average path length and the betweenness score.
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A side product of the filtering of the network for analytical correlation is that structural corre-
lation may also be removed. However, if the experiment has been designed and carried out well
then the variation in the QC samples will be less. There will be fewer analytical correlations and
due to the lower variation the structural correlations will be weaker.
The filtering method reduces the analytical correlations which could lead to FP links. Those
FP links could be interpreted as significant biological links. Multiple testing correction was also
performed on the p-values of the filtered network. This lowers the p-value cut-off for signifi-
cance, which in turn causes more edges to be removed. Consequently, the edges that remain will
almost certainly be due to a biological correlation. As network based analysis has become more
prominent in the field the risk of trying to identify a pair of metabolites, a lengthy process, of a
non-biological relevant link would be a time consuming process for no reward and could lead to
a false hypothesis.
4.4 Conclusion
In conclusion, there are many different types of correlations in liquid chromatography mass spec-
trometry data. The correlations that are structural have been explored by publications such as
Kuhl and Alonso et al. We have further defined how well correlation alone can classify struc-
turally related pairs. We examined ROC curves for adducts and isotopes independently which
has not been previously investigated. It is also clear that a retention time window is needed for
classification of structural pairs. Without retention time windows correlations just as strong that
are either biological or analytical correlations may be found. By removing structural links from
the global correlation distribution a set of correlations could be seen in both sets of sample cate-
gories, biological and QC samples. The QC sample correlation distribution should have only had
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Figure 4.8: Network statistics to show the difference between the unfiltered biological network
and the filtered network. A) The overlap of the different network using betweenness
as a measure and ranking score shows that the filtered network is very close to the
random delete networks. Yet, the bootstrapping of the biological network is very
different to the filtered network. B) The average path length was calculated for each
random delete network. The filtered network (blue) is clearly substantially different
to the main distribution of the random deletes, and different to unfiltered biological
network (red)
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structural correlation. However, the global correlations distributions are strikingly different from
each other. This correlation distribution for the QC samples was made up of analytical correla-
tion and the biological sample distribution was made up of biological and analytical correlations.
To our knowledge no previous work has separated out these distributions or has studied the cor-
relation at length. The analytical correlations are derived from analytical processes that have a
linear effect, such as degradation of column chemistry, variable sample extraction efficiency etc.
As inference and correlation networks become more popular in the field the risk of including
analytical links in biological networks is prominent. We have developed a method to help re-
move or reduce the amount of analytical correlations and return a high confidence correlation
network. We have shown that the network is statistically different to randomly deleting edges in
the original biological correlation network. It is different on the level of connectivity between
pairs of nodes for the original biological correlation network, random edge deletions and a null
network that is an altered biological network.
This method presented here has many more far reaching effects than just correlation networks
but also any process that relies of pairwise feature metric, such as PCA, MDS, nearest neighbour
approaches and many more.
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5 Using Temporal Correlations as
Biomarker Signatures in Metabolite
Profiling
5.1 Introduction
Time is an experimental parameter that is rarely analysed in great detail in modern high through-
put experiments. However, temporal analysis can yield a better understanding of the dynamics
of the system than simple ’snapshot data’. If used correctly with good quality data the change
from one state to the next can be understood and even predicted.
Classically time series analysis has been preformed at a univariate level. These methods in-
clude auto-regressive (AR) models, moving average (MA) models, combination models such as
autoregressive moving average (ARMA) models and autoregressive integrated moving average
(ARIMA) models, as previously discussed in section 1.8.1. These methods give the ability to
understand the dynamics of the data by using the all of the information available however, since
they are univariate methods they do not consider variable relationship. In general, time series
analysis methods have the potential to:
1. Predict future time points of the series being modelled
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2. Give an understanding of the underlying dynamics (the progression of one state into the
next)
3. Increase the statistical power to accurately classify samples
There is no universally agreed definition of what makes method a temporal method. However,
the method should use the order of the time points to understand the dynamics of the data. This
definition was used by Smilde et al [96]. There are many well received methods that use this def-
inition such as the STEM method [137], TimeClust [138], NETGEM [101] and miniTuba [102].
Here, we define a temporal method as one which uses the order of the time points to model the
data.
5.1.1 Metabolite Time Series
In many high throughput biological experiments there is an interest in finding the difference
between two class states and identifying a statistically significant difference between the two.
Commonly, this is done by evaluating the mean or median feature intensity levels between class
states. Without a second dimension of time the understanding of how the class states interact or
transform into each other is lost.
While traditional metabolite biochemistry experiments, which follow only one or two metabo-
lites or a certain pathway commonly have a temporal aspect, this is still rare in high throughput
metabolite profiling experiments. The cost of running multiple samples and the need for repeated
sampling from the study individuals across time reduces reduces the frequency of these experi-
ments. With little data being generated for these studies there is a lack of metabolomics specific
methods for time series. Some methods such as PCA [56, 139, 140] have been used to show the
temporal trajectories of each study individual. This method is very useful to show toxicology
data, as was the case in the COMET study [139, 141, 142]. The study showed how mice and rats
which were given doses of toxic chemicals moved away from their starting metabolic state and
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then corrected and returned to their previous state. However, this method does not give detailed
information about the dynamics that are happening and it does not use the ordering of the tempo-
ral data in the model. Another way that temporal data is routinely analysed is to look at each time
point separately and perform a univariate test such as a Wilcoxon rank t-test on the metabolites
levels for each time point separately. Again, this method does not use the temporal ordering to
gain more information about the system.
Existing Time Series Methods
Methods such as the smoothing splines mixed effects (SME) models [97] method have been
specifically designed for temporal metabolite data and use the ordering of the temporal data to
detect differences between experimental conditions (classes). This method makes a spline model
of each class so that a median curve is modelled for each condition. Once these median curves
are found a functional t-test can be used to find if the curves are significantly different from each
other. The functional t-test integrates the area between the two curves. By modelling the individ-
ual deviations from the average curve the variance of the test statistic is estimated. Finally, a null
model is estimated via bootstrapping. This method takes into account the temporal nature of the
data by creating a model of the temporal profile. Some models uses aligned continuous curves
of the two expression profiles. By doing so they are able to collapse the data down to simple
chi-squared test. This method has been used to find differently expressed genes with few data
points [143]. Other models also use the continuous curves of B-splines, such as the continuous
hidden process model (CHPM) which is able to assign a biological function to a set of genes
using previously known biological information [144].
Many methods look at the differences between the temporal states [101,145] using networks to
describe these changes. Others look at the a genetic pathway approach again using networks for
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the description [92,146,147]. Correlation of the intensity or counts is an often used and powerful
metric [89, 90, 137]. As previously stated one of the problems with time series data is that it can
be difficult to fit the correct curve to the series. Often this is due to either short time series and or
few biological replicates. A lot of biology tends not to be a linear process. However, nonlinear
methods have a difficulty in being able to fit the model. Pearson correlation requires much less
data to be able to fit the linear model than many nonlinear methods.
Developed Method
Often an interesting and useful way to look at temporal data is to use lags. Lags are used classi-
cally in AR models, to look at the cyclic nature and memory of time series among other values in
the model. With multivariate time series we can compare different time series to each other using
a selected metric. As previously stated Pearson correlation is a powerful metric and is quick to
compute. To best of the authors knowledge there are no methods that use multivariate temporal
lags in metabolite profiling.
Here we present two temporal methods for the discovery of temporal biomarkers between two
or more sample classes. The first method uses metabolite correlation networks to identify similar
processes within classes and differences between classes. The second method presented identi-
fies differences in the rate of the processes between classes. For example if one class has a faster
rate of metabolism than the other class, but the process stays the same, method 2 will identify this
difference. These methods are demonstrated using two different temporal datasets, a pregnancy
study (from chapter 4) and the COMET Hydrazine study [139, 148]. Using these datasets we
are able to show that these methods produce statistically significant results that can help with the
understanding of the temporal structures in these complex datasets.
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5.2 Methods
5.2.1 LC-MS Pregnancy Study
The data was prepared in the same way as the previous chapter 4.2.1. Briefly, 14 women who
were on the same in vitro fertilisation (IVF) trial gave daily urine samples. The 14 women were
split into two classes of successful IVF treatment (P) and failed IVF treatment (NP). The samples
were collected over the whole month. However, there were some missed days and not all of the
women overlapped with the sample collection days of the rest of the group. After filtering the
samples were analysed by an LCT Premier TOF mass spectrometer (Waters MicroMass, U.K.)
with electrospray ionisation (ESI) source. A reversed-phase C18 chromatography method was
run using an Acquity (2.1 mm x100 mm, 1.7 µm) columns (Waters) mobile phases A (water,
0.1% formic acid) and B (acetonitrile,0.1% formic acid). The method was a linear gradient of 14
minutes. Injection volume of 5µL. Quality control (QC) samples were made using a combina-
tion of all the samples. These samples were analysed at the same time and were inter-dispersed
between the samples every 10 samples.
Again the data was processed and extracted in the same manner as in section 4.2.2. The data
files were converted to netCDF files using Waters MicroMass databridge softwareTM and data
extracted using xcms [49] version 1.30.1. The files were separated into classes of P and NP. For
peak detection the centWave algorithm [48] was used with 3-20second peak width and lock mass
correction on [108]. Grouping was performed using the nearest method and retention time align-
ment was done with extra=3, missing=2. The final matrix output of intensities was normalised
using the median fold change normalisation method [74]. Filters applied were a post-processing
minFrac of 50% and a CV filter of 27% on the QC samples, as explained earlier 4.2.2. The final
dataset had 2321 features.
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5.2.2 NMR COMET Hydrazine Study
The historical COMET dataset [139, 141] for the Hydrazine toxicology studies was a suitable
temporal effect study and had a good length time series with many biological replicates. All of the
Hydrazine study data was retrieved from the COMET database [139]. Urine samples of Sprague
Dawley rats were collected over 168 hours (h). An injection of Hydrazine was given to a popu-
lation of rats at 30mg/kg and 90mg/kg dosage. This time point at the injection was time 0, two
time points before this were collected. This gave the following time series −16, −8, 0, 4, 8, 24
hours and then every 24hrs after that up to 168hrs. A final population of 3 classes was made,
no dose, low dose and high dose. There were the following number of replicates in each class
respectively: 26, 28, 24. These samples were collected from 6 different laboratories.
The spectra were collected on 600MHz Bruker spectrometer 1H NMR. This data was archived
and retrieved on the COMET database retrieval system [139]. The intensity data was interpolated
over 0.04 ppm wide bins. Following the binning of the spectrum hydrazine and its metabolites
spectral resonates were removed. The water peak was also removed from the spectra from 6.00-
4.48ppm. Finally, the citrate peaks at bins 2.7 & 2.54 were combined to be two bins such that the
2.7 bin was made up of 0.08 ppm units. The resulting matrix incorporated 200 spectral variables
from 78 individuals across 8 time points.
5.2.3 Computational Method - Univariate Analysis
A Welch’s two sample t-test was performed on each feature between P and NP class, for the
LC-MS dataset across all the time points. For each feature a box plot and EIC were plotted and
checked to make sure that the peaks were real. Bonferroni correction (as defined in eq 1.2) was
performed due to the multiple tests, using the correction factor of 2321.
Next a time point Welch’s t-test was performed. This was done so that each time point was
113
tested separately. However, there were many missing data points in both datasets. For the LC-
MS, IVF treatment dataset, a set of samples that had the fewest missing time points and had the
most time points was found. Missing time points from this set of samples were interpolated over
using linear interpolation. No more than 1 time point was interpolated over and no extrapolation
was performed. The resulting matrix of 14-28 days for the LC-MS IVF treatment dataset and
0-168 equally space at 24hr intervals for the NMR hydrazine study was used for the rest of the
analysis. This gave the LC-MS IVF treatment dataset 9 individuals and the NMR Hydrazine
study remained with the same number (78) of rats as before. After the time point by time point
t-test was performed Bonferroni correction was used, with the correction factor of 2321.
5.2.4 Computational Method - Multivariate Analysis
A principal component analysis (PCA) was performed on the interpolated data matrix. First a
scaling method was chosen to compensate for the heteroscedastic noise. The following scaling
types were tested; unscaled, univariate, Pareto and log base 10. Only the Pareto and UV scaling
were chosen based on their results and a PCA model was made in R using the pcaMethods
package [149]. For each model a Q2 value was generated via the Krzanowski method [150].
The Q2 value helped to decide the scaling method used for the model and number of principal
components (PC) to examine. If the Q2 did not increase from one component to another or started
as a negative then the model was removed as a choice. The number of PC were chosen by the Q2.
If the Q2 did not change from one component to another then the component in which the last
change was seen was used. A scores plot of the resulting model was plotted and was coloured
using class labels of class and individual, separately.
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5.2.5 Computational Method - Intra-unit Temporal Correlations
To analyse the temporal data in a temporal fashion two different methods were designed. The first
method has been designed to find processes that affect metabolites differently between classes
and lags. These differences are between pairs of different metabolites that have a lagged effect
within the individual but have a different lag between the classes.
Using the temporal profile for each feature a pair wise correlation matrix is produced for each
individual. First a 0 delay correlation matrix was made. The equation for this can be seen below.
ρixy = cor(S ix(t), S iy(t)) (5.1)
where S ix is the intensity of feature x in the individual i. Here, x and y represent the different
features. The correlation of all the features generates the correlation matrix ρi for one individ-
ual. Using the same structure the temporal profiles can then be lagged to reveal any common
structures :
ρixyτ = cor(S ix(t), S iy(t + τ)) (5.2)
S (t) is the signal at time (t) and S (t + τ) is the signal lagged by τ. A lagged correlation
matrix ρixyτ is made for each individual subject. Each matrix at lag τ is grouped with the lag
matrices from other individuals at τ. Once all of the required lagged correlation matrices are
made within each individual, each feature pair of correlation coefficients ρ is tested between
classes. A Wilcoxon rank sum test is used to test whether the correlation ρxy(t) are different
between the classes.
Figure 5.1 shows the overall workflow of the method. In Step 1 a classical two class exper-
imental design can be seen with samples being taken over time at equally spaced time points.
These samples are then analysed using a high through-put technique such as NMR or MS. In the
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Figure 5.1: The workflow for method 1. In this method samples are taken over time (1) from
a two class experiment eg KO vs WT. These samples are then analysed with either
NMR or MS. If MS is used then xcms extracts the data and (2) EIC’s are checked for
quality. The EIC’s show two different feature in every class and sample. No obvious
mean difference is apparent. Next each feature’s time profile for one individual is
plotted against the other feature of that individual. At 0 lag there may be no correla-
tion (3) however, at higher delays there may be a high correlation (4). Finally, every
feature pair ρ is compared between classes and each lag τ using a Wilcoxon t-test (5).
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case of MS analysis a program such as xcms can be used to extract the data. Next, each EIC
is inspected (2). The figure shows two different features one in red and the other blue. These
features are from different retention times and are different masses. They are not structural pairs.
In (3) the temporal profiles are plotted for both features against each other. The blue feature is
on the y axis and the red feature is on the x axis. The correlation from these two features is very
low. However, the temporal profiles of the two features appears to be very similar is shape but are
delayed by a few time points. If we delay or lag the time profiles by 4 time points, in this case,
the correlation is now very high (4). The temporal plot next to the scatter plot shows that there
is almost a perfect overlap in the red and blue signals. Also since the profiles are now lagged the
profile is also shorter by 4 time points. Once this pairwise correlation is performed within each
individual subject, the two ρ values can be compared between the two classes. Using a Wilcoxon
test, any significant results can be investigated further. A Bonferroni correction is performed to
control the false positive rate.
5.2.6 Computational Method - Inter-unit Temporal Correlation
Method 2 is designed to capture differences in temporal events between classes. To do this each
feature is correlated with itself between different individuals. Correlations between different fea-
tures are not used due to the complexity of a biological meaning. The correlation is performed
in a pairwise manner for within and between classes. Figure 5.2, shows the general workflow
of method 2. A single feature is selected in both classes, eg KO and WT. The temporal profile
is then correlated in a pairwise fashion between all individuals of that class and between all in-
dividuals of both classes. Each individual is shown as a red (KO) or black circle (WT) coming
from the same feature depicted by the EIC. A line between the circles (individuals) depicts a
correlation. A ρ is calculated for each given τ for each feature:
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ρi jx(τ) = cor(S ix(t + τ), S jx(t)) (5.3) ρi jx(−τ) = cor(S ix(t − τ), S jx(t)) (5.4)
As shown by equations 5.3 and 5.4 the correlation coefficient will be different depending on
which individual, (S i or S j) for feature x is lagged. For lagged correlations the correlation is
performed in both directions, as the correlation will be different. This is because ρi jx(τ) ,
ρi jx(−τ). This is seen in figure 5.2 where the the two correlation plots have a different ρ value
depending the direction of the lag. While this is also true for the within class correlations, the
method is trying to identify a difference between the classes. Consequently, the within class
correlations are not calculated in both directions. In addition to this, the within class temporal
profiles should be similar and so a low variation between the ρ for both directions should be
observed. The correlations in figure 5.2 are grouped so that all green correlation (intra-KO class
correlation) are grouped, separate from blue correlations (intra-WT class correlations). This
results in 4 different classes to compare between; KO-KO, WT-WT, WT-KO, KO-WT. It can
also be seen that the same data lagged in different directions give a different ρ. A Kruskal Wallis
test is performed to find metabolites that are significantly different between classes. The p-values
are then corrected using Bonferroni correction to help reduce for the number of false-positives.
5.2.7 Power Analysis
A power analysis was needed to find the number of samples needed, at 80% power to find a sig-
nificant result of a given effect size. The calculation was performed with a numerical simulation
to test the effect of different sample sizes. Using this simulation allowed for the same amount
of variance and overall distributions of the data to be preserved. The work was carried out in a
similar fashion as Chadeau et al [151] work on power calculations. A logistic model was applied
to to determine if a variable was going to be a case or control. The prevalence of the model
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Figure 5.2: The workflow for method 2. In this method each feature’s temporal profile is com-
pared between and within each class. This comparison is then also performed at lags
and consequently both forward and back directions are needed. Finally the ρ are
compared between and within classes to find the differences between classes.
was set to 50%. This allowed both case and control samples classes to be the same size. The
logistical model followed equation 5.5
P(case) =
eB0+(B1∗ρ)
1 + eB0+(B1∗ρ)
(5.5) d =
x¯1 − x¯2
σ
(5.6)
where B0 is the prevalence of cases. This decided how balanced the classes are going to be,
or the centre point of the logistic function. Since the prevalence was set to 50% this means that
in figure 5.3 this is roughly around the correlation coefficient (ρ = 0), as this was the median of
the distribution. The B1 value controls the effect size. From figure 5.3 a low effect size can be
seen in the top left hand corner of the figure (B0 = 0), whereas a high effect size is seen in the
bottom right hand corner of the figure (B0 = 10).
To run the power analysis on method 1 all of the classes were combined into one dataset. From
this combined class dataset the B0 was set to the median (LC-MS pregnancy dataset −0.016 and
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Figure 5.3: The figure shows the effect on the
probability of a case changing B1
while keeping B0 static. When B1 is
close to 0 the value of the correla-
tion coefficient makes no difference
to deciding if the sample is a case or
control sample. However, as B1 in-
creases then the class description of
case or control becomes more likely
that a high ρ value will result in the
sample being a case.
Hydrazine NMR dataset −0.002) correlation coefficients. Using this combined class dataset the
values were randomly chosen from the distribution. The probability of being a case was then
calculated the sample was assigned to this class accordingly This was repeated until the number
of samples desired was reached. The whole procedure was also repeated 500 times and results
were averaged. The resulting matrix was an effect size given in Cohens d as shown in equa-
tion 5.6. Here, x¯1 and x¯2 are the mean of the two correlation distributions being tested and σ is
the standard distribution of the two distributions.
For method 2 a power analysis was also performed however, as there were 4 groups an effect
size was more difficult to calculate. The results needed to be comparable between the methods
and so a Cohens d was also chosen to express the effect size. However, Cohens d is normally
between two means as shown in equation 5.6. Since method 2 is trying to identify differences
between the classes the means between the two groups were used. From figure 5.2 this would be
the KO-KO and one direction of between class correlations KO-WT.
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5.3 Results
5.3.1 Pregnancy Dataset
Conventional Data Analysis
The IVF dataset was collected using a regular 12 minute reverse phase LC-TOF-MS protocol.
Each patient submitted urine samples over the course of a month, resulting in 279 samples with
a time range spanning from 12 days to 40 days. There were 9 failed IVF pregnancies (NP) and 5
successful IVF pregnancies (P). The raw data was analysed with xcms. This processing resulted
in 32,721 features. Features that were not present in either class of NP or P in at least 50%
of the samples were removed. This makes the data more reliable and limits the possibility of
false positives. The number of features after this removal was 4915. Using the QC samples the
coefficient of variation (CV) could be calculated for each feature on the unfiltered data. This gives
a measure of how much analytical variation there is. The median CV was 28% and the mean was
38% with the minimum being 7% and the maximum being 591%. These CVs are higher than
expected for a LC-MS dataset. A typical value being around 15-20% median CV [63,68]. Using
both the minFrac and CV filters (filter of median CV of 28%) the resulting dataset was 2321
features.
Normally with snapshot data i.e. non-temporal data, a simple t-test can be preformed to find
the most significant result that differentiates the means of the two classes as shown in chapter 1.9
figure 1.4. Figure 5.4 shows the top two results from a mean level analysis using a Welches t-test.
The p-values that are below the Bonferroni cut-off of 0.01 alpha are 1.46E−13 for M659T367 and
1.46E−13 for M223T375. Both of the results show a good peak, from the EIC plot. The box plots
show that the QC samples have a low amount of variation. However, even though these features
have passed all of the selection criteria the there is a high amount of variation in the up-regulated
samples. This is due to the experimental design of the time course. A few time points have high
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intensity whereas some have a low intensity.
A B
CD
Figure 5.4: The figure shows two significant features from the mean level comparison via a t-
test. Below the two EICs are the box plots showing the differences in median level
intensity for the three classes of failed IVF (non-pregnant), successful IVF (pregnant)
and Quality control samples (QC).
While this method produces some results it does not take into account the dynamic nature of
the data. As previously stated the variability is very high. To understand the dynamics the tempo-
ral nature must be taken into account. A widely used method is to take each time point separately
and perform a t-test on the features. This means that the number of samples will decrease as the
full time course is not being used. The variation should also decrease as longitudinal variation
has been removed. This is under the assumption that all of the individuals are metabolising at the
same rate and that there is a biological event that has synchronised all of the individuals together.
122
The collected data has many gaps in the temporal profile. This is due to failed sample collec-
tion from the individuals. To allow a full temporal profiling for the each patient a simple linear
interpolation was performed. This interpolation was then checked manually for each feature. In
total no more than one separate time points were interpolated over, in each individual. After this
operation there were 15 continuous time points from 14-28 days in 9 individuals. Many individ-
uals had to be removed as they either had too many time points missing or did not overlap with
the other individuals. The final result was a continuous time profile that overlaped on all of the
patients therefore allowing for a comparison between the individuals and classes. The NP class
had 5 individuals and the P class had 4.
Performing the T-test on each time point gave no significant results after Bonferroni correction.
Bonferroni correction is a very conservative method of correcting for family-wise error rates.
There is also an inherent problem associated with performing the analysis in this fashion. This
form of analysis makes the assumption that the different classes are at the same metabolic rate.
This is to say that the same metabolic activity is happening on day 14 in all individuals.
Another typical analysis with temporal data is to perform a multivariate analysis. The most com-
mon is principal component analysis (PCA). While PCA does not take into account the temporal
nature of the data, temporal trajectories can be visualised, which can help in the analysis and
understanding of the biological data. As previously stated, PCA can be highly influenced by
different scaling methods. The scaling method needs to be chosen as to reduce the amount of
variation in the dataset and need to be chosen so that equal weight is given to the variables. In
multivariate datasets there can be a different amount and different distributions of variation on
the variables. This quantity is known as heteroscedasticity. A good way to test which scaling
method will reduce the heteroscedasticity is by plotting the rank mean of each feature intensity
vs standard deviation of the intensity [74]. Figure 5.5 shows 4 different scaling factors using the
above-described method. If a scaling method is removing or limiting the heteroscedasticity noise
then the overall trend should be flat. The test does not work very well for univariate scaling as
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Figure 5.5: Four different plots
showing the effects
of heteroscedasticity
after various scaling
methods. In black is
the unscaled data, red is
univariate scaling, blue
is pareto scaling and
green is log10 scaling.
Plots without a trend
show a reduction in
heteroscedastic noise.
all features have a standard deviation of 1 by definition. However, we can tell that the un-scaled
data has heteroscedasticitic noise associated with it. The log scaling has also not been able to
remove all of the noise, while the pareto scaling has done a better job there is still a trend of high
standard deviations at high and low ranks.
A PCA model was made for the best two scaling methods, univariate and pareto scaling. The
Q2 value is a estimate of how predictive the model is. This value should increase with the number
of component of the model. However, as seen in figure 5.6 the Q2 value decreases in the pareto
scaling model. This means that the 2nd component is not valid and so only the 1st component
is valid. For this reason the pareto scaling was dropped for further analysis. The score plots in
figure 5.7 show the 1st (20% R2) and 2nd (8% R2) principal components. There is no obvious
temporal trend in the scores plots and there is a spread of the individuals.
Trying to get an accurate metabolic descriptor from this analysis can be difficult. The loadings
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Figure 5.6: The Q2 and R2 of two different
scaling methods, Pareto and uni-
variate scaling. The Pareto scaling
PCA models shows that the Q2 val-
ues decreases after the 1st compo-
nent. However, the univariate scal-
ing roughly increases linearly until
the 5th component.
plot will describe the features that move the samples away from the centre (away from the P
class). But these descriptors will mainly be individual specific as demonstrated by figure 5.7b.
To understand this data better more individuals would be needed.
A method is needed where the dynamic nature of data is taken into account. A temporal
statistical t-test was developed and published called SME (Smoothing spline Mixed Effect mod-
els) [97]. This method uses smoothing splines to make an averaged temporal profile for the
different classes and then uses a functional t-test to test for significance. The functional t-test
integrates the area between the median temporal profiles for each class and then compares this
to a bootstrapped null model. While this test is very applicable to this data, the written software
was unable to run on the very high number of features in the dataset. A simple reduction of
the number of features used was not applicable as the results would not be comparable between
methods. Also, a suitable selection of features was not able to be found.
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Method 1
After correction with Bonferroni there were no significant results. At first this result was surpris-
ing as we believed that there should be some differences over time between the two classes in
some process between the metabolites. The most likely reason for this is a low statistical power.
If we consider the effect size as in equation 5.6, then we can see from x¯1 − x¯2 that the maximum
would be +1 − −1 = 2. Consequently, the distributions would have to be very tight to have a sig-
nificant p-value if the number of samples is kept small. With the small sample set and the limited
maximum effect size both contribute to the limited power. To demonstrate that power was the
reason for negative results a power calculation was done for the method using the existing dataset.
Power Analysis
The simulation used a specific lag to generate the correlation matrix used for the data input to the
simulation. Correlation values were assigned a class using a logistic function. This process was
repeated for increasing numbers of samples to a maximum of 100. Figure 5.8 shows the results
of this simulation. Using the closest simulated sample size to the true sample size the median
effect size was 0 with a 3rd quartile of 1.2 and a maximum of 15.3. However, even with this high
effect size the p-value was only 0.0153. This p-value would satisfy an alpha of 0.05 but with
false positive discovery correction or Bonferroni correction this p-value is no longer significant.
With so few samples it is difficult to get a large enough effect size which will be significant af-
ter multiple testing correction. A minimum of 35 samples are needed to get 80% power at an
effect size of 2.0. This effect size was not reached with the low number of samples in this dataset.
The power analysis highlights some of this issues with this method. The method requires a
median to long time series (> 10 time points) so that the ρ value can be accurately estimated.
This has not been shown here with the power test but non-accurate ρ values would increase the
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Figure 5.8: Mean power curves
for different number of
samples. The power
is plotted against the
Cohen’s d effect size.
variation in the effect size. The power analysis shows that the method requires > 25 samples for
a dataset with this variation. This requirement for a large sample size is partial due to the limited
range of effect sizes. If the two classes have a maximum effect size i.e. one class ρ = −1 and the
other class was ρ = +1, this is the maximum difference in means possible. This limit translates
to a limit in the maximum effect size. The theoretical effect size is still infinite however, this
depends upon the standard deviation being very small.
Method 2
Another analysis to perform using correlation is to look at the correlations of the intensities of
the features (metabolite) between individuals. This method looks for a lagged onset of a signal
from the same feature between classes. The ρ were tested in a 4 way Kruskall-Wallis test. The
groups are the two within class correlations and the two between class correlations. The between
class correlations are different at different lags as seen in figure 5.2. This method was tested and
after using Bonferroni correction on the results a few features were still significant as shown in
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Figure 5.9: Each mean curve is a
power simulation. The
x axis shows Cohens
d. Since both of the
between class correla-
tions are chosen as con-
trol classes the differ-
ence can be demon-
strated using Cohens d.
The Cohens d
table 5.1.
Power Analysis
Again a power analysis was performed to test how much power the method had. The same
logistical model was used as in the previous example. For the method there were 4 classes. This
meant that the two classes from the logistic model are repeated twice. These classes were: two
cases and two control classes. The cases were the between class correlations and the controls
were the within class correlations. A Cohens d was used between one case and one control. This
allowed a comparison between the two methods in terms of power. For this analysis the number
of observations is 20. While there are only 4 and 5 sample in the P and NP the number of pair
observations is 20. Looking at the graph this means that there is sufficient power to be able to find
a significant result. If 80% power is used then an effect size of 1.8 with 20 samples is possible.
Table 5.1 shows the features which were significant. To try and identify the metabolites the
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CAMERA package was used [51]. This uses a correlation based algorithm to collect adducts,
fragments & isotopes into groups. This analysis easies the identification process by characteris-
ing the feature and related features thereby allowing for identification of the molecular ion.
Effect m/z RT Pseudo Metlin KEGG
Name p-value Size Lag med med ID ∆ppm ID ID
M326T212 4.5×10−7 1.7 1 326.08 212
M328T243 4.0×10−7 1.9 1 328.10 242 Als Cys Cys 4 18736
M299T391 1.7×10−5 1.5 1 299.23 390 NSC-76989 15 70609 C15117
M281T391 9.7×10−6 1.3 1 281.22 390
M539T409 6.1×10−7 1.5 1 539.25 409
M513T409 9.0×10−7 1.8 1 513.31 409 PA(10:0/10:0) 9 40925
M328T243 1.0×10−5 1.6 2 328.10 242 Ala Cys Cys 4 18736
M328T243 2.4×10−6 1.4 3 328.10 242 Ala Cys Cys 4 18736
M242T181 1.6×10−5 1.4 4 242.09 180 Vitamin B5 16 70034
M446T405 8.0×10−6 1.6 4 446.28 404 Trp Leu Lys 14 17082
M172T201 2.7×10−6 1.7 5 172.09 200
Table 5.1: Results from method 2 of the Pregnancy data. These non-0 lag results were significant
after Bonferroni correction (α = 0.05, correction factor 2321). The metabolite ID’s
are still preliminary.
From this analysis the molecular ion and consequently the neutral mass could be found. After
this a search was performed in Metlin, KEGG and HMDB [82,83,85]. If a result was present then
the CAMERA [51] spectral plots were used to look at fragments of the correlated group. Using
the characterised fragment masses from the CAMERA plots the MS/MS databases in Metlin and
HMDB were used to tentatively identify the features. These results are still very preliminary
however, such results as vitamin B5 and the tri-peptides are encouraging. It is known that thyroid
problems are a key factor during pregnancy and that the thyroid is responsible for many different
signalling processes [152, 153]. Doctors recommend for women with thyroid problems to finish
treating these problems before starting on IVF treatments [153]. The thyroid sends many mes-
sages to the body via small peptides, such as Thyrotropin-releasing hormone (TRH). It must be
remembered that the identities of the metabolites are preliminary and so no conclusion can be
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draw from these pseudo ID’s. To secure the identities of the metabolites which would be needed
before any more analysis is done, MS/MS and retention time mapping against a pure standard
would be required.
5.3.2 COMET Dataset
Many of the long time series with many biological replicates are toxicology experiments. The
COMET project was is a very large study and investigated how the exposure of toxins effected
a biological system. One of the larger studies was a hydrazine study. This study was carried out
over many different labs. There was a total of of 78 animals in 3 different classes of low dose
(n=28), high dose (n=24) and control (n=26). This study was chosen to increase the amount of
power for methods 1 and 2. For the analysis the low dose vs control was used as these classes
had the highest number of samples.
As a first analysis of the data and to see that the data was the same as the original publication, a
PCA model was made [139, 142, 154]. This was carried out in the same fashion as before using
no scaling, the scores plot of the first two principal components (54% and 15% R2 for the first
two components respectively) is shown in figure 5.10. It shows the same trend as before, where
the higher dose group animals are shifted outside of the main group of control and low dose. As
the time course continues the trajectories return to the original position. The data was treated
with the same single time point interpolation as the pregnancy dataset. All time points were used
for the interpolation, −16 to 168 hours. However, so that the time points were equally spaced
the pretreatment times were dropped from the analysis. Consequently, the remaining time points
were every 24hr starting at 0hr − 168hr.
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Figure 5.10: A PCA scores plot
of the Hydrazine data.
The scores plot shows
a similar pattern as the
published data.
Method 1
Method 1 was run on the COMET Hydrazine NMR data. Briefly, this method identifies feature
pairs that have similar temporal patterns at a lag and where these correlations are statistically
different from the other class. Using this method on the COMET Hydrazine NMR data a lot of
significant features were seen at 0 lag. These significant results are similar to a STOCY analysis.
The 0 lags do not use the temporal information of the data and a better assessment can be done
using T-tests or multivariate methods. Removing the 0 delay results table 5.2 shows the results
using the temporal information.
Due to the large ppm width of the original binning, identification of the spectral resonaces was
complicated. Each of the results were checked to make sure that the spectral bins were not noise
and contained real peaks. While this excludes that the results were erroneous it is more difficult
to say which signal in the bin was the main contributor to the significant result. More work
needs to be done with reprocessed high spectral resolution binning or with integrated identified
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Bin1 (ppm) Bin2 (ppm) Lag p-value Effect Size
2.24 2.24 1 8.33e−07 1.6
1.12 6.48 2 5.58e−08 1.7
1.12 1.76 3 4.26e−08 1.7
1.12 1.68 3 5.91e−07 1.6
1.12 1.64 3 1.04e−08 1.9
2.28 1.60 4 2.82e−08 2.1
1.64 1.60 4 9.32e−07 1.6
1.60 1.60 4 3.28e−07 1.8
1.52 1.60 4 1.04e−06 1.6
2.28 1.56 4 6.38e−08 1.9
1.80 1.56 4 1.17e−06 1.6
1.52 1.56 4 5.26e−07 1.6
6.44 0.96 4 3.28e−07 1.8
Table 5.2: Non zero delay results from Method 1 on the Hydrazine COMET data
compounds (e.g. using BATMAN [60]). The identified compounds would add to the confidence
of the results, aiding a biological explanation. Figure 5.11 shows the results from method 1.
Figure 5.11a & 5.11b show the differences in ρ between the control and low dose classes in the
form of box plots. Both of the plots show a difference in the median ρ between the control and
low dose classes resulting in highly significant p-values. These plots were chosen as they are
some of the most significant p-values and have a clear correlogram plot.
Power Analysis
As with the pregnancy dataset, a power analysis was performed, figure 5.12. This analysis al-
lowed confirmation that the results with the observed level of significance was viable and that
with enough samples the method does have enough power to identify lagged temporal events
with reasonable effect sizes. The power curve has been produced in the same fashion as the
previous study. The highest effect size observed in this study was 2.05. The number of samples
used was 26 samples, this gives a maximum effect sizes of 2.05 for > 80% power.
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(a) Box plot of ppm pairs (b) Box plot of ppm pairs
(c) Correlogram of ppm pair (d) Correlogram of ppm pair
Figure 5.11: Method 1 applied to COMET Hydrazine NMR data. (a) & (b) Two box plots for the
control (type1) vs low dose (type 2) with the y-axis as the correlation coefficient ρ;
Two correlograms (c) & (d) show ρ for each sample in each class across the different
lags. It can be seen that (c) ρ is most different at delay 3 and that (d) is most different
at delay 4. The effect sizes are 1.7 and 2.0 for the two results as seen in table 5.2
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Figure 5.12: Power curves from
NMR COMET Hy-
drazine temporal
metabolite data. The
power curves are from
temporal analysis
method 1.
In figure 5.12 where the green line represents 25 samples. As expected, with more samples
there is more power, but there is also a sharp pick up in the amount of power after 10 samples.
This is suggestive that with the variance in this dataset somewhere between 20 to just below 40
samples is optimum. With the observed effect sizes in this dataset a larger number of samples
would be preferred as many of the effect sizes have a lower power than 80%. The mean effect
size of the significant results is 1.7. This gives a power of 42%.
Method 2
Method 2 was also run with the Hydrazine data. With the larger sample size more power was ex-
pected and consequently more reliable results. In total there were 368 results from 0 lag, whereas
the non-zero lags gave much lower number of significant results (38, 23, 29 results for lag 1, 2
and 3 respectively). Many of these results had p-value below 10−9 while some had p-values below
10−23. These p-values are low due to the high number of pairs used to calculate the test statistics.
The method uses each pair between and within class groups to calculate the p-value. This means
that rather than the actual number of biological replicates for each temporal profile used (26 vs
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(a) Box plot of 1.76 ppm pairs at lag 3 (b) Box plot of 3.08 ppm pairs at lag 1
Figure 5.13: Method 2 applied to COMET Hydrazine NMR data
28) the test actually uses all of the pairs of temporal profiles. In this larger study this come out to
be a lot of pairs, 676, 728, 728 and 784 pairs for the within control group, control vs low dose,
low dose vs control and within low dose respectively. As it can be seen these numbers are much
higher than the numbers of individuals and the data in each class are not independent. Conse-
quently, the p-values are more overly optimistic than they should be. It is difficult to correct for
these effects and the analysis was performed assuming independence but using the conservative
bonferroni multiple testing correction to limit false positives. Bonferroni correction lowers the
p-value for significance and so was helpful in removing some FP hits. Below, in figure 5.13 are
two of the most significant results from this analysis; ppm 1.76 at a lag of 3 and ppm 3.08 at a
lag of 1.
In figure 5.13a a strange result can be seen where the median correlation within the the low dose
groups has a negative median correlation. This shows poor within group similarity, along with
the control group having a close to 0 median correlation. The amount of variance in the distri-
bution of each box is very large. Again, due to the artificial increase in sample size the p-value
remains highly significant at 1.52×1098. Figure 5.13b shows a higher within class similarity and
ρ. The between class comparisons have a negative ρ. This is very interesting and suggests that
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Figure 5.14: Power curves for
COMET Hydrazine
NMR temporal data,
using temporal analy-
sis method 2.
the features have a negative feedback between each other. The temporal profile plots for these
features is not revealing as the amount of variation (even on a normalised scale) between the
temporal profiles is quite large.
Power Analysis
To see how much power was possible with the increased number of samples a power analysis
was done in the same way as with the previous study. Figure 5.14 shows the results from the
power analysis. The number of biological replicates was 26 and 28. Since each feature is only
being compared to itself across and within classes there should only be 1 comparison for each
biological replicate. However, as previously shown (figure 5.2) the lags means that both direc-
tions of the comparison need to be considered. Therefore the smallest group has 676 pairs. This
means that even small effect sizes have a lot of power. This can be in figure 5.14 where almost
all of the power curves hit 100% power by an effect size of 2.0.
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5.4 Discussion
Temporal metabolite profiling is still new and many methods are not available or the current
coding does not allow a full scale analysis. Some methods, such as the SME algorithm [97] are
limited because they are computationally intensive. A highly reduced dataset could have been
produced by filtering however, these results would not comparable to the results discussed here
as the methods here use the whole dataset. Other non-temporal metabolite profiling methods
have been used such as PCA. These results were able to show some overall trends. However,
these trends did not show temporal trajectories in the case of the pregnancy data but in the case
of the Hydrazine NMR COMET data the PCA shows both smooth temporal trajectories and class
differences. The t-tests that were done on mean levels at each time point also did not show any
difference between the classes with multiple testing correction. As previously stated this high-
lights the need for specialised temporal methods.
It was particular noted that the pregnancy dataset had a higher variation than the NMR Hy-
drazine dataset. Some of the variation can be attributed to the known lower reproducibility in
LC-MS datasets [63, 65, 68, 155]. In addition to this the pregnancy dataset was also a human
dataset and so consequently had more biological variation than the highly controlled Hydrazine
rat study. The increase in variation is seen in the difference between the power curves where a
smaller effect size is needed in the NMR Hydrazine study data to achieve equivalent power. For
example to achieve 80% power in the LC-MS pregnancy dataset 35 samples were needed with
an effect size of 2.0, in the NMR Hydrazine dataset only 26 samples were needed to achieve the
same power with a similar effect size. Also the variation can be seen in the PCA plots of both
the NMR Hydrazine data and the LC-MS Pregnancy dataset. Due to this increased variation the
pregnancy dataset needs more biological replicates to be able to obtain equivalent power as the
NMR study. As shown in the previous chapter the amount of analytical variation in the Preg-
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nancy dataset was enough to create some analytical correlations. However, these correlations
were at 0 lag. The processes that causes the analytical correlation are highly unlikely to correlate
different metabolites through their time profile. Therefore, a lagged temporal correlation will be
unlikely to be caused by an analytical process. The analytical variation will however, decrease
the ρ if there is a true biological correlation for both method 1 and method 2.
The question of variation in the biological dimension also raises the question of synchronisa-
tion of the individuals. Here, method 1 is unique in that it does not suffer from non synchronised
individuals. This is because the correlation networks are made within the individual, there is no
cross individual connections. Only the correlation coefficient is compared at the end between
classes. Unfortunately method 2 is effected by synchronisation of the individuals as it correlates
across individuals. This means that if the individuals are metabolising at a different rate or dif-
ferent starting points the method will not work as designed.
While the datasets were from different species they were both urine. Urine datasets can have
more variance than plasma or tissue datasets. Unfortunately obtaining other fluids was not pos-
sible for both studies. In the pregnancy study it would be unethical to collect endometrial tissue
and even daily plasma samples would be difficult. For the Hydrazine study the rats would not
have enough blood for daily collection. This was unfortunate as tissue would have allowed for
a greater understanding and more targeted analysis of the temporal data. With the body fluids,
especially urine, it can be difficult to understand what the process is that is causing the correlation.
In method 2 the p-values in the Hydrazine study are abnormally low. While this means that
they pass the Bonferroni correction and are very significant it is unexpected. The reason for the
values being so low is due to the number of samples used in the test. Due to the way in which
the test is uses pairs rather than single data points the number of test samples is an artificially in-
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creased number. Overall the amount of false positives could be increased. While the Bonferroni
cutoff is used exactly for this purpose we believe that the correction may not remove the stated
number of false positives.
Overall, both methods have been shown to yield useful results that would not have been de-
tected if a temporal metabolite profiling method was not used. Identification of metabolites is
still a time consuming and difficult venture however, a final validation of the methods is the bio-
logical understand and explanation of the results.
Others work in transcriptomics have used lags on small datasets of micorarrays [92]. Zoppoli et
al showed that a biologically meaningful network could be reconstructed using a temporal ex-
tension the the ARACNE [156] algorithm. The algorithm used the mutual information between
transcripts at different lags to build up the network. However, this work did not compare between
class groups to find statistically significant transcripts between classes. Others have also looked
at elucidating pathways [157]. Lecca et al also uses a lags Pearson correlation network to ”infer-
ence ... pharmacokinetic network”. The networks explain the response of the system to a drug or
stimuli. Again, these networks do not analyse the difference between two biological class states.
We have developed and demonstrated two temporal metabolite profiling analysis methods. The
methods have the ability to detected lagged signals or events happening between classes without
the need for temporal synchronising of biological replicates. Method 2 is able to detect signif-
icantly different lags between classes of the same process. The results show that the methods
picks up different metabolites and with enough samples are able to find statistically significant
results. We believe that with further developments that these methods and framework will help
to promote new temporal algorithm for metabolite profiling.
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5.5 Future Work
While both methods have shown that they are able to identify new connections in the data there
are improvements that could be made.
• Pre selection filter on features - This could be done in numerous ways:
Sub grouping:
A method could be used to subgroup the different temporal trends into a set number of
profiles such as was used in the STEM [137] algorithm. After this method has placed
the features into different groups they the most similar and most different could be
compared between biological classes.
Smooth trends:
Temporal profiles that are smooth trend may be less likely to be noise profiles
Similarity metrics:
Within class similarity metric for removal of features with low within class similarity.
A similarity identifier to find features that have a high similarity within the biological
class would allow for a higher degree of confidence in the final results. This would
also reduce the amount of computational time required for the comparison. This
would be specifically for method 2, but could be extended to method 1 if the network
level was used instead.
• Development of a better statistical test for method 2. This developed method would ac-
count for the artificially increased test samples and their non independent nature.
• To be able to run the tests in a multivariate fashion. For method 1 this could be done by
fitting a smooth spline to all temporal profiles within the individual. Then common fea-
tures between individuals but within class could be combined to find the median fit within
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the class. Knowing the variance between the median fit a correlation with the included
variance could be used to assess the difference between the classes. This could be done in
much the same way as in SME [97]
• Partial correlations. The use of partial correlations would shrink the ρ and reduce the
network size removing correlations that were spurious and false positives.
• Use of a non-linear metric such as Mutual information (MI). As previously stated, most of
metabolism is not linear. Using a non-linear metric such as MI may help to find biological
relationships between the pairs. MI also does not have an upper bound and so the issue
associated with using Pearson correlation of a maximum of ρ = +1 and a minimum of
ρ = −1 would not be seen with MI.
The above list addresses some of issues which were met during the analysis of the datasets.
However, the use of the two datasets with both method 1 and 2 is a demonstration that lagged
structures in temporal metabolite profiling can help to explain temporal data and adds another
dimension to the analysis.
These methods have shown that there is a wide area of research needed not only in temporal
metabolite profiling but in this 3rd level analysis. We have simply shown a two class analysis
with lags. With more classes and a well designed experiment the within classes lags could be
tested as a predictive model for the other classes. Nevertheless, the temporal lags are a new and
unexplored area in temporal metabolite profiling.
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6 Conclusion
In conclusion we have shown that the aims of the thesis were realistic and have demonstrated
methods to resolve the problems discussed. Some of these problems are inherent in the data as
part of the profiling of metabolites, while others are specifically due to the platform that has been
used.
6.1 Correction of Mass Calibration Gaps in LC-MS
The existence of mass calibration gaps in LC-MS data was a previously unknown and unsolved
problem associated with the raw data. This problem could not simply be resolved using a smooth-
ing filter on the peaks as not all of the peaks were accurately detected. The method described
has been able to increase the confidence for all of the detected peaks. The integrated intensity of
the detected peaks was restored along with a decrease in the false negatives of detected peaks.
This software was publicly released and is part of the open source software suite, XCMS [49].
While no computation solution will be able to perfectly restore the lost intensity, the current
method alters the expected peak shape due to its design. This solution was taken since it is fast
and accurate. This method could be improved upon by using interpolation to return the expected
peak shape. Another way would be to apply a smoothing filter to the raw data after the mass cal-
ibration gaps have been filled. It is debatable how much the accuracy would be improved by this
approach in comparison to the extra computational time required. However, the filling method
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could also be used for recovering lost intensity when MS/MS experiments are being performed.
6.2 Inter- and Intra-Lab Reproducibility of LC-MS in Urine
Metabolomics
The chapter shows that UPLC-MS-TOF is a reproducible technique to be used across multiple
labs at different times. This study was essential in being able to understand what is the expected
and accepted amount of analytical variability within the lab and how this changed between labs.
The study demonstrated that across lab studies, if well designed, are capable of generating highly
valuable information. One of the main problems in analysing the data was the change in source
settings which meant that different compounds and different adducts were detected. To resolve
this, an in-depth study which changes the source settings one parameter at a time and analyses
the changes in adduct formation and intensity of those adducts is needed. This would allow for
a better understanding of why and how the adducts were made and what, if any, source setting
should be changed between instruments and between labs.
To be able to examine the data, all of the spiked-in compounds needed to found in their var-
ious adduct forms. The software that was made to find these adducts proved highly useful and
versatile. However, this also meant that only the selected spike-ins were analysed. A larger study
with a highly complex mixture of labeled compounds, needs to be analysed in this same manner.
This would enable a wider range of compounds to be detected and a wider range of endogenous
metabolites intensities could be studied. Such a study would also have the drawback of only
generating data on one biofluid. However, it is the authors opinion that these studies would be
extendable to other biological matrixes.
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6.3 Characterising the Static Correlation Structure in LC-MS
We have shown that not only are labeled compounds detectable with accurate RT windows but
that, with the use of Pearson correlation, adducts and isotopologues can be confirmed with a
high degree of confidence. As more software platforms have started to use correlation for iden-
tification of structurally related compounds, this is an important and needed step. However, as
previously discussed there are many other metabolite pairs that have a high correlation. These
other correlated pairs are either biological correlations or analytical correlations. The analytical
correlations may prove to be problematic for downstream analysis where metabolite to metabo-
lite relationships are considered. This was shown using metabolite correlation networks however,
methods such as PCA and other factor analysis will also be affected. It is important to note that
such methods as PCA are widely used in the field. These analytical correlations could prove very
time consuming to researcher following up false biological separations. An automated check in
PCA methods to remove these correlations or limit them should prove useful to the field.
While this higher level of reproducibility or variably was shown using a linear metric it is ex-
pected that a non-linear metric would also show analytical relationships which may require re-
moval. As these linear and non-linear analytical relationships are discovered the cause of them
needs to be studied in greater detail so that this level of reproducibility can also be limited and
tested for. Further computational research could be directed towards studying how to separate
the analytical distribution without impacting the biological correlation distribution.
6.4 Lagged Correlations in Temporal Metabolite Profiling
Two new and different methods were developed for the 3rd level analysis of metabolite data.
These lagged temporal analyses have been shown to be able to extract new and different infor-
mation from the dataset compared to traditional methods. Like many temporal methods they
suffer from low power which in our case prevented further biological analysis. Further to this is
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the fact that the current implementation of these methods uses a linear metric. Most metabolic
reactions would not lead to simple linear relationship and so consequently some relationships
may not be detectable. As discussed in the chapter, these methods are a development into the
3rd level analysis for temporal metabolite data processing. Both of the methods developed have
shown that more work is needed in this third level analyses. This area of research promises
to help produce more temporal data and to further develop temporal metabolite understanding
through the use of the temporal lags.
6.5 Summary
Overall we have seen that there are many different levels of reproducibility in LC-MS datasets
and that higher levels of reproducibility is based on the mean level (level 1) reproducibility. We
have been able to develop new methods to help increase the reproducibility of the data, identify
and remove feature pairs that are not reproducible. We have shown that the structural pairs can be
identified with confidence. As proposed in the framework another level of analysis is the lagged
temporal level. This level requires further analysis, however two novel methods have been pro-
posed and are able to successfully identify new relationships in the data.
This thesis covers many different areas of research with a focus on reproducibility of data
within the presented framework. This framework gives new levels for analysis of metabolite
profiling data and omics data in a whole. Further work on extending this framework to ‘lag’
between the different omic technologies would help the understand of not only the metabolites
but the biology in question.
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7 Appendix
Name Charge Mass Difference
[M + H]+ +1 1.01
[M + 2H]2+ +2 2.01
[M + 3H]3+ +3 3.02
[M + Na]+ +1 22.99
[M + Na]2+ +2 22.99
[M + 2Na]2+ +2 45.98
[M + K]+ +1 38.96
[M + NH4]+ +1 18.03
[2M + H]+ +1 1.01
[2M + Na]+ +1 22.99
[2M + K]+ +1 38.96
[M + 2K]2+ +2 77.93
[M + 2K + H]+ +1 76.92
[M + H + Na]2+ +2 24.00
[M + H + K]2+ +2 39.97
[M + Na + K]2+ +2 61.95
[M −C3H9N]+ +1 -59.07
[M + H −CH4S O]+ +1 -62.99
[M + H −CH4S ]+ +1 -47.00
[M + H −C6H10O5]+ +1 -161.04
[M + H −C6H10O4]+ +1 -145.05
[M − H]− -1 1.01
[M − 2H]− -2 2.01
[M − H2O − H]− -1 19.02
[M-OH]- -1 17.00
[M+Cl]- -1 -34.97
[2M-H]- -1 1.01
[M+CO2]- -1 -43.99
[M-2H+Na]- -1 -20.97
[M+K-2H]- -1 -36.95
Table 7.1: A list of the possible adduct formations with the charge states and mass difference.
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Setting A Pos A Neg B Pos B Neg C Pos C Neg
Ref Scan Freq 50 50 15 15 20 20
Ref Cone Voltage 40 40 50 50 30 30
TTP 4GHz YES YES Yes YES Yes Yes
Dynamic Range Enhancements YES YES Yes YES Yes Yes
mode W W W W W W
Capillary voltage 3000 2500 2700 2000 3000 2800
Sample Cone Voltage 40 40 50 50 30 30
Desolvation Temp 380 380 400 400 300 300
Source Temp 120 120 150 150 120 120
Cone Gas Flow 10 10 50 50 40 40
Reflectron Voltage 1800 1800 1800 1800 1800 1800
MCP detector 2800 2750 2000 2150 2100 2200
Trigger Voltage 600 600 600 650 600 600
Signal Threshold 20 20 90 90 60 60
m/z range 85-1000 85-1000 85-1000 85-1000 85-1000 85-1000
cycle time 0.11 0.11 0.11 0.11 0.16 0.16
Scan Time 0.1 0.1 0.1 0.1 0.15 0.15
inter scan time 0.01 0.01 0.01 0.01 0.01 0.01
Table 7.2: Instrument settings from the different labs
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(a) Lab A Positive
(b) Lab B Positive
162
(a) Lab C Positive
(b) Lab A Positive
163
(a) Lab B Positive
(b) Lab C Positive
Figure 7.2: This EICs for each of the labelled compounds seen if table 3.1
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Figure 7.3: Between-lab reproducibility for pairs of labs in positive and negative mode, including
acetyl carnitine. Each data point corresponds to a single standard compound adduct
averaged across all replicates at a single dilution. Each standard is indicated by a
different colour and a separate linear regression line. Key: positive mode: red acetyl
carnitine, green - DL-leucine, black - DL-methionine, purple - dopamine, pink - Hip-
puric, orange - L-DOPA, light green - nicotinamide. Negative mode: red - Succinic
acid, Green - Hippuric acid, blue - Glutaric acid, Black - CL-phenylalaine.
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Compound Comparison R2
acetylcarnitine-d3 @ [M + H]+ Lab C vs B 0.840
acetylcarnitine-d3 @ [M + H]+ Lab C vs A 0.960
acetylcarnitine-d3 @ [M + H]+ Lab B vs A 0.710
Adipic acid-d8 @ [M + H]+ Lab C vs B 0.980
Adipic acid-d8 @ [M + H]+ Lab C vs A 1.000
Adipic acid-d8 @ [M + H]+ Lab B vs A 0.990
DL-leucine-d3 @ [M + H]+ Lab C vs B 0.990
DL-leucine-d3 @ [M + H]+ Lab C vs A 0.950
DL-leucine-d3 @ [M + H]+ Lab B vs A 0.950
DL-methionine- 13C @ [M + H]+ Lab C vs B 0.990
DL-methionine- 13C @ [M + H]+ Lab C vs A 0.950
DL-methionine- 13C @ [M + H]+ Lab B vs A 0.970
dopamine-d4 @ [M + H]+ Lab C vs B 0.920
dopamine-d4 @ [M + H]+ Lab C vs A 0.870
dopamine-d4 @ [M + H]+ Lab B vs A 0.980
Hippuric acid-d2 @ [M + H]+ Lab C vs B 0.970
Hippuric acid-d2 @ [M + H]+ Lab C vs A 0.960
Hippuric acid-d2 @ [M + H]+ Lab B vs A 0.960
L-DOPA-ring-d3 @ [M + H]+ Lab C vs B 1.000
L-DOPA-ring-d3 @ [M + H]+ Lab C vs A 0.860
L-DOPA-ring-d3 @ [M + H]+ Lab B vs A 0.830
nicotinamide-d4 @ [M + H]+ Lab C vs B 0.980
nicotinamide-d4 @ [M + H]+ Lab C vs A 0.930
nicotinamide-d4 @ [M + H]+ Lab B vs A 0.930
Table 7.5: Between Lab Reproducibility, (Positive mode
)
Compound Comparison R2
Succinic Acid-d4 [M − H]− Lab A vs B 0.499
Hippuric Acid-d2 [M − H]− Lab A vs B 0.960
Glutaric Acid-d4 [M − H]− Lab A vs B 0.994
DL-phenylalanine- 13C [M-H2O-H]- Lab A vs B 0.998
Table 7.6: Between Lab Reproducibility, (Negative mode)
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Name m/z RT(sec)
1 Alanine 89.0480 20
2 Hypotaurine 109.0197 24
3 D-Proline 115.0633 40
4 TLC-A 152.0473 255
5 Uric Acid 168.0283 70
6 L-Citrulline 175.0957 40
7 Asorbic Acid 176.0321 176
8 Hippuric Acid 179.0580 232
9 3-HPPA 180.0423 235
10 Citric Acid 192.0270 73
11 caffeine 194.0804 264
12 L-Tryptophan 204.0900 200
13 Uridine 244.0700 125
14 Chenodeoxycholic acid 392.2930 550
15 ADP 427.0290 70
16 3-Hydroxybutaric acid 104.1073 100
17 1,3 Dimethyluric acid 196.0596 180
18 1-Methyladenine 146.0714 150
19 1-Methylnicotinamide 137.0715 230
20 1-Naphthol 144.0575 160
21 11-Dehydro-thromboxane 368.2199 270
22 11-Hydroxyandersterone 306.2195 300
23 2-Aminobenzoic acid 137.0477 150
24 2-Furoic acid 112.0160 175
Table 7.7: Identified Metabolites in Urine used for Dataset A
Name m/z RT(min)
1 Adenosine 268.1032 2.0900
2 Glycerophocholine 258.1095 8.3300
3 Inosine 137.0453 3.0800
4 Iso-Butyl-carnitine 232.1533 6.4600
5 Lidocaine 543.3280 6.0000
6 CPA 415.2110 0.7190
7 L-PC 520.3396 6.0000
8 Hypoxanthine 137.0453 2.2100
9 Uridine 243.0613 1.4000
Table 7.8: Identified Metabolites in Arterial Plaques used for Dataset B
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